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1. HSE Primary Care Eligibility & Reimbursement Service
 (PCERS) 
1.1   What is the role of PCERS? 
 
The Primary Care Eligibility & Reimbursement Service (PCERS) is part of the HSE. It is 
responsible for processing payments to healthcare professionals; GPs, Dentists, Pharmacist 
and Optometrists/Ophthalmologists who provide free or reduced cost services to the public.  
In addition to the processing and making of payments on a national basis to healthcare 
professionals, the PCERS compiles statistics and trend analyses which are provided to other 
areas within the HSE, the Government, customers, stakeholders and to members of the public.  
Almost all payments for services provided in the community by General Practitioners, 
Community Pharmacies, Dentists and Optometrists/ Ophthalmologists are made by the 
PCERS.  Claim data is processed and payments are made by the PCERS under the following 
Schemes/Payment Arrangements: 
 General Medical Services (GMS) 
 Drugs Payment Scheme (DPS) 
 Long Term Illness Scheme (LTI) 
 Dental Treatment Services Scheme (DTSS) 
 European Economic Area (EEA) 
 High Tech Drugs (HTD) 
 Primary Childhood Immunisation Scheme (to Doctors) 
 Health (Amendment) Act 1996 
 Methadone Treatment Scheme 
 HSE Community Ophthalmic Services Scheme (HSE-COS) 
 Immunisations for certain GMS Eligible Persons 
 General Practitioner Visit Card (GPVC) 
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2. Schemes and Eligibility   
2.1   General Medical Services (GMS) Scheme  
 
Anyone who is ‘ordinarily resident’ in the Republic of Ireland can apply for a medical card or 
GP visit card. This includes families, single people, even those working full or part-time. 
‘Ordinarily resident’ means that you are living here and intend to live here for at least one year. 
Being eligible for a medical card depends on your circumstances. If a person does not 
automatically qualify for a medical card, an assessment is carried out and is based on income, 
expenses, marital status and dependants.  
You automatically qualify for a medical card if you: 
 are participating in certain government schemes 
 have been affected by the drug Thalidomide 
 have had a surgical Symphysiotomy 
 are a child diagnosed with cancer within the last 5 
years 
 are in foster care 
 live in direct provision 
 qualify under EU Regulations 
 are under the Redress for Women Resident in Certain Institution Act, 2015 
 are under 16, whose parents are receiving a Domiciliary Care Allowance (DCA) 
 have been affected by the National Cervical Check (including dependents) 
Once eligibility is confirmed, patients are entitled to receive certain Doctor, Dentist, Clinical 
Dental Technicians (CDT’s), Optometrists or Ophthalmologists treatments/services and 
prescribed medicines from Pharmacists as set out under each scheme. 
The eligible person registers with the doctor of his/her choice and is entitled to receive free 
doctor, dentist and optometrist/ophthalmologist treatment and certain prescribed 
medicines and appliances other than the relevant prescription charge from the list 
approved by the Minister for Health. 
Each GMS eligible person is issued with a laminated plastic medical card by the HSE, 
which contains the person’s name, medical card number and other information embossed 
on it.  All cards are valid for a particular period of time and contain a ‘Valid To’ date.  Where 
the patient’s circumstances change the card may be withdrawn prior to the ‘valid to’ date 
on the card. Third generation computer systems conduct this seamlessly. 
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2.2   GP Visit Card  
 
Persons with a GP visit card, don't have to pay to see the doctor. However, they will have to 
pay for medicines and other services. Those with a medical card, do not need a GP visit card. 
Anyone can apply for a GP visit card. Applications for GP visit cards and medical cards are 
made through the same system. A person will first be assessed for a medical card. If they 
don't qualify, they are then assessed for a GP visit card. 
 Those over 70, can register for an over 70s GP visit card. 
 Those with a child under 6, can register for an under 6s GP visit card. 
 Those in receipt of Carer’s Benefit or Carer’s Allowance, at full or half rate, can visit 
the GP for free 
 
 
2.3   Drugs Payment Scheme (DPS) 
 
Under the Drugs Payment Scheme (DPS) an individual or family will pay no more than the 
amount set out in the Regulations each calendar month for: 
 approved prescribed drugs and medicines 
 rental costs for a continuous positive airway pressure (CPAP) machine 
 rental costs for oxygen 
Anyone who is ‘ordinarily resident’ in the Republic of Ireland can apply. ‘Ordinarily resident’ 
means that you are living here and intend to live here for at least one year. There is no means 
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2.3.1 Family Applications 
 
A family is an adult, their spouse or partner and any dependents. You can include any family 
member, regardless of age, who can't fully maintain themselves and has: 
 a physical disability 
 an intellectual disability 
 an illness 
A medical report is required for the applicants who cannot maintain themselves. 
Dependants over 18 years and under 23 years of age who are in full time education may also 
be included. In this instance, confirmation from the dependent’s education institution must be 
provided.  
1) The names, dates of birth, gender, and Personal Public Service Numbers of all members 
of the family unit must be listed on the DPS application form, which should also designate 
an adult member as Head of Household for the purposes of the Scheme. 
2) The Address and telephone number of the Client / Family should be provided. 
3) When registering children, the Child’s PPS Number is required. Where children’s PPS 
numbers are not readily available, the Registration Section of the Department of Social 
Protection will assist.  
4) Dependants over 18 years and under 23 years of age who are in full time education may 
be included by ticking the appropriate box. Additional verification will be required, either 
through a college stamp or letter. 
5) Any Change in circumstances e.g. birth, death, medical card registration, dependant(s) 
leaving full time education should be notified to the HSE.  
 
2.3.2 Express DPS Registration 
 
Under the Drugs Payment Scheme (DPS), families and individuals ordinarily resident in 
Ireland pay a maximum amount in any calendar month for certain prescribed, drugs, medicines 
and or appliances. 
From 26th November 2018, the PCERS made available a new process for online express 
applications by the Community Pharmacist. This online application is available on the 
10 
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Pharmacy Suite named “Emergency DPS”. Once this module is clicked you will be able to 
launch the application and read the user guide. While this process will facilitate DPS eligibility, 
this is on a temporary basis only. Pharmacists should advise the customer to apply for ongoing 
eligibility online or complete an application form.  
Failure to register for the DPS scheme will result in losing DPS eligibility after 3 months. The 
‘Emergency DPS Pharmacy User Guide’ is accessible within the ‘Emergency DPS’ module on 
your pharmacy suite. 
 
 
2.3.3 Submitting Applications 
 
Applications for the DPS can be undertaken either online at www.myDPS.ie using our 
dedicated online application facility or, by completing an application form and posting to:- 
Drugs Payment Scheme,  
Client Registration Unit,  
PO Box 12966,  
Dublin 11, 
D11 XKF3.  
Further information regarding DPS can also be accessed through www.medicalcard.ie or 
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2.4   Long Term Illness (LTI) Scheme  
 
A completed long-term illness scheme application form is sent to the PCERS. The application 
form can be downloaded from the HSE website and posted to; 
Long-Term Illness Scheme 
Client Registration Unit 




To qualify, a person must be ‘ordinarily resident’ in the Republic of Ireland. 
This means that they are living here and intend to live here for at least one 
year. Certification by the doctor or consultant is required on the LTI application form submitted 
to PCERS to confirm the condition including the list of medication and appliances needed to 
treat the condition.  
Once the application is successful, the patient will be issued with an LTI card. The patient is 
provided seamlessly with the Core List for their prescribed illness. Patients with the following 
medical conditions listed should register on the LTI scheme immediately following diagnosis. 
Further information regarding LTI can also be accessed through www.hse.ie/lti  or LoCall 1890 
252 919. 




Illnesses and Disabilities 
A Intellectual disability (This is described in the legislation as ‘mental handicap’) 
B Hydrocephalus 
C Cerebral Palsy 
D Muscular Dystrophy 
E Haemophilia 
F Diabetes Mellitus (does not include Gestational Diabetes) 
G Diabetes Insipidus 
H Epilepsy 
J Multiple Sclerosis 
K Parkinsonism 
L Cystic Fibrosis 
M Phenylketonuria (PKU) 
N Acute Leukaemia 
Q Spina Bifida 
P Mental Illness – only for persons under the age of 16 years 
R Thalidomide - for conditions arising from the use of this drug 
12 
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2.4.2 Express LTI Registration 
 
Pharmacists now have the facility to express register LTI applications for certain long-term 
illnesses where the medications prescribed confirm the diagnosis. The online registration 
facility is available on the Pharmacy Suite named ‘Express LTI’. 
 
While there are 16 illnesses and disabilities covered by the LTI scheme, there are certain 
illnesses where it is clear that the medications prescribed confirm the diagnosis. Pharmacists 
can apply for the following under the LTI scheme; 
Illness 
Code 
Illnesses and Disabilities 





These represent the vast majority of LTI applications. All other illnesses and disabilities cannot 
be applied for by the Pharmacist using the express LTI registration.  
Once the patient has been registered, an LTI number will be provided with the confirmation of 
registration. Claims for approved products on the Reimbursement List can be submitted under 
the LTI scheme using this number. All applications made can be viewed in the ‘Application 
History’ tab.  
The pharmacy should advise the patient to complete the application form and submit to 
PCERS. They will have 2 months to complete this process. Further claims will not be paid if 
registration has not been completed in this timeframe.  




2.5   Health (Amendment) Act, 1996  
 
The Government has provided in the above Act, for the making available without charge of 
particular health services to certain persons who have contracted Hepatitis C directly or 
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indirectly from the use of Human Immunoglobulin-Anti-D or the receipt within the State of 
another blood product or blood transfusion. GP services, pharmaceutical services, dental 
services and optometric/ophthalmic services provided under the Act are paid for by the 
Primary Care Eligibility & Reimbursement Service. 
Persons eligible under Section 2(1) (b) of the Act are entitled to receive drugs, medicines and 
medical and surgical appliances, which are prescribed by a medical practitioner, free of 
charge. Homeopathic Medicines or Herbal Medicines are not reimbursed by the Primary Care 
Reimbursement Service. Arrangements similar to those in place under the Drugs Payment 
Scheme (DPS) apply in relation to this service but without the need for the person to pay a 
contribution towards the cost of medication and appliances supplied. There is no requirement 
for the person concerned to have their prescriptions dispensed from the same pharmacy in 
respect of the same month.   
2.6   European Economic Area (EEA) Entitlements 
 
European Regulation 883/04 gives entitlement to citizens of the European Union (EU) and of 
the European Economic Area (EEA) to health entitlement when they move to another EU/EEA 
state, either on a permanent basis, such as  for retirement or on a temporary basis, such as a 
holiday or seeking employment. E.E.A. visitors are entitled to emergency treatment only. EEA 
Visitors are required to bring with them sufficient supplies of their routine medicinal 
requirements.  Continuation therapy, including the issue of GMS repeat prescription forms, 
should not be involved. 
It should be noted that the eligibility of such persons is based on their linkage to the Social 
Security System of another EU/EEA State and not on their Nationality. 
For persons moving on a permanent basis the linkage is established by the production of the 
relevant E Form, e.g. E106, E109, E 121 or S form.  
Such persons who are moving to Ireland on a permanent/long term basis should be advised 
to apply for a medical card under EU Regulations. 
For a person who is just visiting on a temporary basis such as a holiday the linkage is 
established by the production of a European Health Insurance Card (EHIC) or a Temporary 
Replacement Certificate (TRC) 
It should be noted that there is an agreement between Ireland and the UK which does not 
require the use of an EHIC or the production on an E Form.  These are referred to later on in 
this section.  
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EEA persons presenting for Dental treatment should in the first instance be referred to a Health 
Service Executive Dental Clinic. The Health Service Executive may in certain circumstances 
make special arrangements for private practitioners to provide treatment to such persons but 
the resulting claim must be made directly to the Health Service Executive Community Health 
Office concerned. Hence if dental treatment becomes necessary contact should be made with 
Community health office first.   
Please note a European Health Insurance Card only provides entitlement to services when 
the holder of the card is travelling within the EU/EEA and outside of their own State. These 
arrangements do not cover persons who come to the Country specifically for the purpose of 
obtaining medical treatment. 
 
2.6.1  European Health Insurance Card (EHIC) Entitlements 
 
Such persons, who are visiting Ireland on a temporary basis, e.g., for holiday purposes, are 
entitled to receive, without charge, the necessary medical care, including such approved 
medication which a Doctor may prescribe, which would allow them to remain in Ireland in line 
with their original planned scheduled. 
As indicated above the normal method by which a person provides evidence of eligibility under 
these arrangements is by producing a current European Health Insurance Card, EHIC, or a 
current Temporary Replacement Certificate, TRC, issued by their Competent State.   
Those persons presenting for Dental treatment with an EHI Card should in the first instance 
be referred to a Health Service Executive Dental Clinic.  The Health Service Executive may in 
certain circumstances make special arrangements for private practitioners to provide 
treatment to such persons but the resulting claim must be made directly to the Health Service 
Executive Community Health Office concerned. A list of HSE Community health offices is 
available at http://www.hse.ie/eng/services/list/1/LHO/.   
Please note a European Health Insurance Card only provides entitlement to services when 
the holder of the card is travelling within the EU/EEA and outside of their own State. These 
arrangements do not cover persons who come to the country specifically for the purpose of 
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2.6.2 Reciprocal Arrangements with the UK 
 
There is no change to the existing arrangements between Ireland and the UK, and residents 
of either Country travelling to the other on a temporary stay are not required to present a 
European Health Insurance Card or an equivalent paper form.  Proof of residency is sufficient. 
A resident of the UK must produce documentary evidence of such residence.  Patients 
claiming UK residency can establish eligibility for free Doctor services under the GMS Scheme 
by producing documentary evidence of their entitlement to services in the UK in the form of a 
UK Medical Card, Social Security Payment from the UK or other link to the Social Security 
system.  Should such proof not be readily available and where a Doctor has sight of a current 
passport or similar documents, which would establish bona fide residence in the UK, such 
documents may be accepted as evidence of eligibility.   
If the doctor has reason to believe that the person, while in possession of such documentation 
is, in fact, ordinarily resident in the State, the person should be asked to have his/her eligibility 
confirmed by the National Medical Card Unit Lo Call Number 1890 252 919. 
 
2.7   High Tech Arrangement  
 
Commenced in November 1996, the High Tech Arrangement provides for the supply and 
dispensing of High Tech medicines through Community Pharmacies.  
The medicines are purchased by the HSE and supplied through Community Pharmacies for 
which pharmacies are paid a patient care fee by the Primary Care Reimbursement Service 
each month.  Examples of high-tech drugs are: anti-rejection drugs for transplant patients, 
chemotherapy and growth hormones.  
These arrangements are designed to provide a quality community based service to patients 
by ensuring the active involvement of community pharmacists in the dispensing of High Tech 
medicines. The arrangement is coordinated centrally through the PCERS High Tech Co-
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2.8   Opioid Substitution Treatment Scheme  
 
The Methadone Treatment Scheme commenced in October 1998.  Under the Scheme 
Methadone is prescribed and dispensed by doctors and pharmacists for approved clients. 
Patient Care fees under this Scheme are paid to participating doctors and pharmacists.  
Persons who present to the registered medical practitioner for treatment must be notified to 
the Health Service Executive (HSE) and placed on the Central Treatment List (01-6488640, 
9am to 5pm Monday to Friday). The HSE issue an ‘opioid substitution treatment card’ in 
respect of a person participating in a programme of treatment in accordance with the 
regulations. The individual will have a treatment card number beginning with PH which is 
unique to them.  
2.8.1 Central Treatment List 
 
The Central Treatment List contains information on all persons for whom 
methadone/suboxone treatment has been prescribed.  The information contained in this list is 
based on information that must be supplied by doctors under Regulation 3 of the 2017 
Regulations. Information contained in the Central Treatment List is confidential. 
 
2.8.2 Drug Treatment Card 
 
An Opioid Substitution treatment card is issued in respect of all patients notified to the Central 
Treatment List.  The card contains the name and photograph of the relevant patient and the 
name of the patient’s doctor and pharmacy.  The card is sent directly to the patient’s pharmacy 
where it is held on behalf of the patient. 
Prescriptions for the treatment of opiate dependent patients may only be dispensed for 
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3. Schemes Administration 
3.1   General Medical Services (GMS) Scheme 
 
Persons with medical card eligibility are issued with a GMS prescription form where medically 
indicated by a Doctor with a GMS panel number. These prescriptions are dispensed and 
claimed under the GMS scheme.  
 
The Health (Amendment) (No 2) Act 2010  provides that a person who is supplied by a 
Pharmacy who is contracted to provide services on behalf of the HSE, with a drug, medicine 
or medical or surgical appliance on the prescription of a Registered Medical Practitioner, 
Registered Dentist or Registered Nurse Prescriber, will be charged a fee per prescription item.  
Fees are capped at a certain amount per person/family per month according to current 
legislation. Charges are recouped from payments due to the pharmacy. 
 
A spouse or a cohabiting partner, children under 16 and children aged over 16 and under 21 
who are in fulltime education and wholly or mainly maintained by another adult person who 
has full eligibility will constitute a ‘family’ for the purposes of applying the charges. 
 
Payment of a single prescription charge for a family unit commences from the date of family 
registration with the HSE. Where a client does not have access to the internet, pharmacists 
can offer to register the family on the HSE website www.medicalcard.ie to obtain the family 
certificate.  Claims for any additional charges paid prior to the date of family registration will 
not be refunded. 
 
Patients, who have their medicines changed on a weekly/daily basis, including palliative care 
patients, will be subject to the charge.  However, for ‘Phased Dispensing’ the phased element 
of the dispensing, where such applies, does not attract a separate prescription charge. For 
completeness, the Non Dispensing Fee will not attract a prescription charge. 
 
Persons who are homeless and not in a residential centre and who have their own medical 
card will be required to pay the charges. In the case of persons who are homeless and who 
live in a residential setting the provider of the accommodation will be required to pay the charge 
on behalf of each resident and make the necessary arrangements for collection of the charge 
from the residents. 
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For persons who hold a medical card and are residing in nursing homes, either HSE or Private, 
or a Residential Disability Centre, the provider of the accommodation will be required to pay 
the charge on behalf of each resident and make the necessary arrangements for collection of 
the charge from the residents. 
 
A prescription charge will also apply for patients accessing products: 
 using Hospital Emergency Prescriptions 
 using Dental Prescriptions under the Dental Treatment Scheme 
 under the EEA Scheme 
 under the Discretionary Hardship Arrangements 
 any claimed strength of a particular product e.g. Warfarin. 
 
There are a limited number of exemptions from prescription charges: 
 
1. Children who are in the care of the Health Service Executive under the Child Care Acts 
1991 to 2013.  All other GMS clients will be subject to prescription charges. Carers 
responsible for children in care will pay the prescription charge to the pharmacy and 
claim a full refund from the HSE PCERS. 
2. The supply of Methadone/Suboxone to Opiate Dependent Clients. Methadone clients 
will be required to pay the charge on prescription items other than methadone. The 
supply of Methadone/Suboxone for non-opiate dependent clients is not exempted. 
3. Persons with full eligibility, i.e. valid medical card living in Direct Provision  
4. High Tech Products. As the supply of High Tech Medicines operates on the basis of a 
patient care fee, a prescription charge will not apply. 
5. Persons affected by the National Cervical Check Service (and their dependents) 
6. Holders of a Redress for Women Resident in Certain Institutions Act 2015 Services 
Card 
7. Health Amendment Act Card holders 
 
The charges do not apply to the Long Term Illness Scheme, the Drugs Payment Scheme, and 
High Tech Arrangements. 
 
A prescription charge will not be deducted from your GMS payment in respect of persons 
confirmed as exempt from prescription charges. 
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Enhanced visibility under Patient Specific Arrangements on the Secure Checker will assist in 





3.2   GMS Repeat 
Repeat prescription sets are for use by participating doctors when they intend that a particular 
item or items be repeated and repeat dispensing is a legally permissible option. 
The “Repeat Prescription Set” consists of three “two-part” sets of self-carbonising forms, the 
top copy of which is the original prescription (White).  When a doctor wishes to have a 
prescription for a GMS patient repeated once the patient should be issued with Part 2 and Part 
3, i.e. two “two-part” sets - the remaining Part 1 should be shredded - if 2 repeats are required 
the complete set should be issued.  It is important that all parts of forms issued are legible. 
Each “Repeat Prescription Set” must have the patient’s name, address and current medical 
card number entered thereon. Only claims where the patient had full GMS eligibility within 2 
months of the date of claim and Incomplete Claims Percentage is decreasing progressively or 
the percentage is 0.1% or less will process for payment.  
Only current eligible medical card numbers should be submitted for reimbursement. Only 
claims where the claiming patient had full GMS eligibility within 2 months of the date of claim 
and the claiming pharmacy Incomplete Claims Percentage is decreasing progressively or the 
percentage is 0.1% or less will process for payment.  
Each original form (white) must be signed by the doctor. 
20 
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The Misuse of Drugs Regulations, 1988 and 1993, and the Medicinal Products (Prescription 
and Control of Supply) Regulations, 2003 apply to GMS repeat prescription forms as they 
would to GMS standard prescription forms or other prescriptions. 
Medical preparations contained in Schedule 1A of the Medicinal Products (Prescription and 
Control of Supply) Regulations, 2003, are not repeatable unless the doctor explicitly specifies 
by writing, “Repeat (once or twice)”.  Prescriptions for Schedule 1A drugs which are not 
specifically so indicated cannot be repeated. 
Controlled Drugs in Schedule 2 and 3 of the Misuse of Drugs Regulations 1988 must not be 
written on a repeat prescription form under any circumstances. 
Nicotine Replacement Therapy and Oral Nutritional Products are not reimbursable on GMS 
repeat prescriptions. Repeat prescription forms should also not be issued to EU/EEA visitors.  
A patient who has been issued with a Repeat Prescription Set is required to present the 
complete set to a pharmacist for dispensing.  
On first dispensing the forms comprising Part 1 (i.e. the last two forms of the set) pharmacist’s 
Claim Form and a Pharmacy Copy should be detached from the set in the dispensing 
pharmacy where the dispensing pharmacist will stamp and date the original prescription form 
with the pharmacy name and address and the date of dispensing in the space provided 
marked ‘1st dispensing’. The remaining forms should be returned to the patient. The 
pharmacist’s Claim Form should be completed with the signature of the dispensing 
pharmacist. 
On second dispensing the forms comprising Part 2 of the set should be used and the same 
sequence as for the first dispensing should be followed.  
On third and final dispensing the forms comprising Part 3 i.e. the original prescription form and 
a pharmacy copy should be used. The pharmacist will retain both parts of the set and will 
stamp and date the original form in the space provided for '3rd dispensing'.  
The pharmacist’s Claim Form and the original prescription forms should be submitted for 
payment to the Primary Care Reimbursement Service by the claiming pharmacists as Regular 
or Exception Claims and entered as such on the Summary Forms with other GMS claims.  
The pharmacist must always dispense against the original Prescription Form (Part 3) which 
should be stamped clearly with the date of dispensing. Pharmacists should not accept for 
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dispensing Part 1 and 2 of a Repeat Prescription set without simultaneous presentation of Part 
3 by the patient. After each dispensing any unused portion of the repeat prescription set should 
be returned to the patient. The patient should not receive a repeat supply earlier than the 
doctor expressly provides, or, sooner than intervals the pharmacist may reasonably infer from 
the quantity and/or dosage stated on the prescription.   If an earlier supply is necessary in any 
other circumstances, the pharmacist should set out the reasons for the departure from normal 
procedure. 
Repeat prescription forms should be submitted grouped together (i.e. not interspersed with 
standard GMS prescription forms) and located after the standard forms in the monthly claim 
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3.3   Hospital Emergency  
Those with GMS eligibility who are provided with a prescription on their discharge from a 
Hospital or residential palliative care setting (hospice) can obtain a maximum of seven days’ 
supply without undue delay through the Hospital Emergency Scheme. The following 
arrangements are in place for this scheme; 
 
1 A dispensing pharmacist must be satisfied that a named authorised person, is at the 
time of dispensing, eligible under the GMS scheme, 
2 Unified Claim Forms must have attached thereto a photocopy of the relevant 
hospital/hospice prescription, 
3 The medical card number of the person prescribed for and the hospital doctor code 
‘61559’ must be inserted in the space provided on the claim form, 
4 Dispensing of emergency supply shall be on the day of issue of a hospital/hospice 
prescription in special circumstances an emergency supply may be dispensed on the 
following day, 
5 GMS reimbursable items only may be claimed for under this arrangement, 
6 The person to whom dispensed items are handed over must sign for receipt of same 
in the space provided on the claim form. When a person other than the named person 
is collecting drug/medicines under this arrangement, the relationship of such person to 
the GMS named person should be recorded on the form.  
 
Neither Private Hospitals nor Out-Patient Department (OPD) prescriptions are covered by 
these arrangements. See Circular 35/17 for a comprehensive list of hospitals and hospices 
approved under the Hospital Emergency Scheme. 
 
3.4   Dental Treatment Services Scheme (DTSS) 
 
The Dental Treatment Services Schemes (DTSS) is available to medical card holders over 16 
years. Dentists will prescribe for GMS persons on specially designed prescription forms. The 
DTSS prescription form is a two-part set. The top copy is the original prescription form and the 
duplicate is the pharmacy copy. The payment of DTSS claims is based on the reimbursement 
price and the relevant GMS dispensing fee. 
Claims in respect of the Dental Treatment Services Scheme must be fully coded and should 
be submitted under separate cover with GMS claims. Incorrect or incomplete prescription 
forms may be rejected for payment. Claims in respect of the DTSS should be included with 
GMS claims. Claims should be tagged as a separate bundle using the appropriate summary 
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form. Payment of these prescriptions is included with your GMS payment each month and 
reported on the GMS itemised listings. 
The List of Dental Prescribable Items is available at www.pcrs.ie > online services > General 
Services- Available to All.  
 
 
3.5   European Health Insurance Card (EHIC) Prescriptions 
 
EU Prescription Forms should be submitted as ‘EEA Claims’ on the claim certificate and 
summary of claims form. 
The top copy is the original prescription form for submission to the HSE upon dispensing in 
order to claim payment, the second copy should be retained by you for your records and the 
third copy is retained by the GP for record purposes. 
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3.6   Drugs Payment Scheme (DPS)  
 
Persons with DPS eligibility are issued with a private prescription where medically indicated 
from the doctor. These prescriptions are dispensed and claimed electronically under the DPS 
scheme. The patient and/or family grouping does not pay over the co-payment as set out in 
legislation in respect of approved reimbursable items. The claim is submitted at the end of the 
calendar month to the PCERS for payment. The Pharmacist receives payment from the 
PCERS for the balance over the monthly co-payment threshold in respect of each family 
group.  
 
Products must belong to a category eligible for reimbursement under the DPS Scheme. The 
List of GMS Reimbursable Items can be found at www.pcrs.ie. Compression hosiery and 
Nicotine Replacement Therapy (NRT) are not reimbursable under DPS.  
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3.7   Long Term Illness (LTI) Scheme  
 
Drugs, medicines and non-drug items reimbursable under the LTI Scheme are intended for 
the treatment of the primary condition. Core Lists were developed following detailed 
consultation with Medical Officers, HSE Pharmacists and HSE Medicines Management 
Programme. The HSE is satisfied that all medicines that should be necessary for the treatment 
of each primary LTI condition are provided on these Core Lists. 
Approved medicines and appliances can be found online at https://www2.hse.ie/services/long-
term-illness-scheme/approved-medications.html. A link is also available to Pharmacists 
through the Secure Scheme Checker. These lists will be updated when changes are made.  
LTI prescriptions are dispensed and claimed electronically under the LTI scheme. The patient 
must have an LTI number in order to submit a valid claim.  
Since April 2019, the Secure Scheme Checker allows pharmacies to see the products that a 
patient has specific individual approval for outside of the Core List(s). These items can be 
claimed for seamlessly under the patient’s LTI eligibility. 
The Secure Scheme Checker system also has the facility for the pharmacist to seek 
reimbursement approval for a product on the Reimbursement List under LTI. This will appear 
on the screen as ‘To request additional drugs for this patient click here’.  
 
In this facility, the Pharmacist must select the product they wish to apply for, upload a copy of 
the hospital prescription and any supporting documentation for consideration.   
The application will remain at pending approval until a reimbursement decision has been made 
and communicated back to the Pharmacist through the system. Once the item has been 
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approved it will appear in the list of LTI product specific approvals for that patient on the Secure 
Scheme Checker.  
Where medicinal products that are not on the approved list are prescribed for the first time for 
a person with any of the LTI conditions, the patient should be informed that the products are 
not on the Core List approved under the LTI Scheme and must be paid for under the Drugs 
Payment Scheme where the patient does not hold medical card eligibility. 
Applications will require pharmaceutical assessment and it may take up to 3 working days 
(Monday to Friday, or the first working day after a weekend) before approval or non-approval 
will be communicated back to the pharmacy by the PCERS through the Secure Scheme 
Checker. While the application is under consideration, ‘pending’ will be displayed on the 
screen. The reason for a negative reimbursement decision will be communicated back through 
the system. 
Applications are made on an individual patient basis. Where insufficient clinical information is 
provided to enable a positive reimbursement decision, an application will not be approved. It 
must be clear that the medicine requested is treating the primary LTI condition. 
 
3.8   High Tech Arrangements 
 
A pharmacist will obtain High Tech medication(s) from their pharmaceutical wholesaler using 
the appropriate ordering facility.  The High Tech Ordering and Management System (High 
Tech Hub) was introduced in 2017 and is managed by the PCERS High Tech Co-ordination 
Unit. Pharmacists can contact the High Tech Hub at 01-8647135 or via email: 
PCRS.HiTech@hse.ie  
All High Tech drugs available for ordering via the High Tech Hub must be ordered through that 
medium to be reimbursed by the HSE. The Hub can be accessed via the Pharmacy Application 
Suite. The list of the drugs available for order on the Hub are located on the Help tab of the 
High Tech Hub. Also available on this Help tab, is the Hub User Guide and FAQs. To order 
via the Hub, you must have a valid High Tech prescription. All orders are per person, per drug. 
The PCERS hope to reduce all stock held to that compatible with immediate patient need and 
seek the co-operation of pharmacists in ensuring that the ‘just in time’ delivery service is 
maximised. See Circulars No. 019/11, 041/17, 054/017 and 016/18 for further information. 
A patient who, on discharge from hospital, is prescribed one or more High Tech item(s) will be 
asked to nominate a community pharmacy where they propose to obtain the prescribed High 
27 
© 2020 HSE Primary Care Eligibility & Reimbursement Service 
 
Tech Medication. In order to register newly initiated patients on High Tech Medicines a copy 
of the prescription must be sent to the High Tech Co-ordination Unit.  If a patient is changing 
pharmacy they must sign the Change of Nominated Pharmacy form and the form should be 
forwarded to the High Tech Co-ordination Unit. Once all medications have been dispensed to 
the patient by their existing nominated pharmacy, HSE will update the change of nomination. 
Note: One monthly Patient Care Fee is payable in respect of each patient registered with a pharmacist 
for whom a claim is submitted.  
 
 
3.8.1 High Tech Non-Dispensing 
 
Because of the need for on-going monitoring by community pharmacists of a patient’s overall 
drug therapy, it is accepted that situations will arise where a pharmacist may claim a patient 
care fee even though no High Tech items have been dispensed in a particular month.  Such 
situations would include, for example, drug regimens/pack sizes that require less than monthly 
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dispensing or intermittent admission of patients to hospital.  However, in these circumstances, 
payment will only be made to the patient’s nominated pharmacy where - 
 
A brief explanation is given on the form of the reason why no High Tech Drug has been 
dispensed and pharmacies must use the code 88999.  
It has been agreed that, in the interests of public accountability, the maximum number of 
consecutive months for which a pharmacist may claim a patient care fee in respect of a 
particular patient, where there has been no dispensing of High Tech medicines for that patient 
shall be three months.  Such a fee may not be claimed in respect of a deceased 
person.  Where a pharmacist becomes aware that a patient no longer requires High Tech 
medication they should inform the HSE. 
 
Pharmacy claims together with the appropriate suppliers delivery docket (or reference to same 
where it has been submitted previously) should be submitted to the Primary Care 
Reimbursement Service under separate cover in an envelope marked HIGH TECH Drugs 
Arrangements not later than 5th day of each month. 
 
3.8.2 Patient Entitlement Categories 
 
Patients must be prescribed the High Tech medication in line with the existing protocol, if 
relevant, in order to be entitled to services under the High Tech Drugs Arrangements.  
Patients will be categorised under one of the following categories 
 Medical cardholders are entitled to all High Tech items from the agreed list free of 
charge 
 Persons covered under the Health (Amendment) Act, 1996 are entitled to all items 
from the agreed list free of charge 
 LTI persons are entitled to an item(s) from the agreed High Tech list free of charge 
only if the item has been authorised for their particular Long Term Condition 
 DPS cardholders will continue to pay relevant copayment as set out in Regulations, 
towards the total cost of all their medication (High Tech and regular medicines)  
 T-number approved in exceptional circumstances such as an emergency where a 
patient is stranded in Ireland and requires High Tech medicines. T-numbers are issued 
by the High Tech Co-ordination Unit. 
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A patient with entitlement under any other Scheme will retain his/her existing authorisation 
number, e.g. Medical Card Number/DPS Card Number; the relevant Patient Number must be 
quoted on Pharmacy claim forms.    
When a pharmacist collects the relevant co-payment as set out in Regulations from a DPS 
person under the Drugs Payment Scheme and where High Tech medicines and DPS 
medicines to the value of the co-payment or more are dispensed to such person, in the same 
calendar month, such pharmacists would be due the full amount of the patient care fee.  
The following examples illustrate High Tech Arrangements with regard to the Drug Payment 
Scheme. 
 An individual or family receives items under the Drugs Payment Scheme in a calendar 
month on the same card grouping to the value of the co-payment or more, pays the 
relevant co-payment as set out in Regulations, to the pharmacist under that scheme.  If 
High Tech items are also dispensed in the same calendar month to the same card 
grouping in the same pharmacy the Primary Care Eligibility & Reimbursement Service 
will credit the pharmacy with the patient care fee. 
 A person with DPS entitlement who has items dispensed under the High Tech Scheme 
only, will pay the relevant co-payment as set out in Regulations, to the pharmacy.  The 
pharmacy account with the Primary Care Eligibility & Reimbursement Service will be 
credited with the patient care fee amount, which will result in a balance due to the 
Primary Care Eligibility & Reimbursement Service of the difference between the patient 
care fee and the relevant co-payment as set out in Regulations in respect of such 
transaction. 
 Where the cost of the High Tech product is less than the co-payment, the pharmacy 
account will be credited with the patient care fee amount and any excess balance will 
be credited to the Primary Care Eligibility & Reimbursement Service.  
 
The remittance advice to the pharmacist will contain a reconciliation of amount paid to the 
pharmacy by eligible persons and the total of patient care fees paid by the Primary Care 
Reimbursement Service. 
Where there is a negative net balance owed to the PCERS by the pharmacy such balance will 
be recouped from other payments that may be due under this Scheme or from any other 
payment due to the contractor.   
Any professional queries that a Pharmacist has relating to the prescription should be directed 
to the prescribing doctor. 
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3.8.3 Annual Stock Take  
 
For the purpose of accounting it is necessary to establish the value of stock held by each 
pharmacy, currently at year-end. The Primary Care Eligibility & Reimbursement Service make 
a list available electronically to each pharmacy containing High Tech drugs ordered by the 
specific pharmacy previously, to assist in compiling the data for the stock take.  Pharmacists 
should confirm the quantity (by the number of units) of each drug on the list held in the 
pharmacy on the specified date. The stock take should be completed electronically using the 
Stock Take options on the Pharmacy Suite. An electronic sign off is required by the supervising 
pharmacist using the options available on the Stock Take system. There is a User Guide and 
FAQ document available to support this process on the ‘Help’ tab of the Stock Take 
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3.9   Opioid Substitution Treatment Scheme  
 
The Misuse of Drugs (Supervision of Prescription and Supply of Methadone and Medicinal 
Products containing Buprenorphine Authorised for Opioid Substitution Treatment) Regulations 
2017 (S.I No 522 of 2017) came into effect on the 22nd November 2017. This has extended 
certain buprenorphine medicinal products authorised for opioid substitution treatment to the 
Schedule of products that fall within the scope of these Regulations. These regulations replace 
the Misuse of Drugs (Supervision of Prescription and Supply of Methadone) Regulations 1998 
(S.I. No 225 of 1998).  
The previous Methadone Treatment Prescription Form has been updated to the Opioid 
Substitution Treatment Prescription Form as a result of the new legislation. See Circular 
013/18 for further details in relation to the Methadone and Opioid Substitution Treatment 
Scheme.  
Prescriptions are for a supply period of not greater than seven days. Where ‘Additional Bank 
Holiday Supply’ is required and indicated on the prescription under ‘Supervision Instructions’, 
a total of eight days duration can be provided. The prescription details are inserted on the 
prescription according to the Misuse of Drugs Regulations 2017 (S.I. No. 173 of 2017). The 
dosage in units i.e. the quantity per day of the preparation and the number of days at that dose 
must be written in the boxes specified on the prescription form. The total dosage in units as 
appropriate, must also be supplied in both words and figures.  
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Claims are processed and paid by the Primary Care Reimbursement Service.  Prescriptions 
must be forwarded to the HSE no later than 14 days after the last day of the month in which 
the supply was completed. Claims are submitted in the normal manner and should be posted 
to:  
Health Service Executive (HSE) 
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3.9.1 Opioid Substitution Treatment Prescription Writing Requirements 
 
All prescriptions must be written on an Opioid Substitution Treatment Prescription form.  It is 
unlawful for a practitioner to issue, or a pharmacist to dispense, a prescription for a Schedule 
2 or 3 controlled drug unless it complies with the following requirements: 
The prescription must: 
 Be in ink or otherwise indelible and be signed by the practitioner with his/her usual 
signature and dated by him/her 
 Contain the full name and address of the patient for whose treatment it is issued. This 
should be clearly displayed at the top of the Prescription 
 The patient’s Opioid Substitution treatment card Number should be entered into the 
space provided for ‘Treatment Card Number’. The letter’s PH, example PH12345, 
precedes the Treatment Card Number. (In the case of a non-opiate dependant patient 
the correct patient identification should be used e.g. medical card number, EEA 
number etc.). 
 Clearly indicate the name of the practitioner issuing it, except in the case of a health 
prescription (GMS), specify his/her name and address 
 State that the person issuing it, is a registered medical practitioner, and the prescription 
details have been completed in full by the prescriber prior to dispensing. This includes 
Date Prescribed, Drug Name, Form and Strength, Treatment period (from – to), Daily 
Dosage, Number of days at dose, Total quantity dispensed should be completed, Total 
in Words, Doctor’s Signature (in accordance with legal requirements), Doctors Number 
and Doctors’ Name, Address and Telephone Number or The pharmacy section of the 
forms must be completed in full and include Pharmacy Number, Drug code, Quantity, 
Number of instalments, Supervised Y/N, Days Supervised and Dates dispensed. 
 The form must be stamped and signed by the pharmacist. 
 The patient must sign the form in the space provided.  
 In the case of a prescription for Methadone or Buprenorphine/Naloxone, for purposes 
other than opioid dependence, the pharmacist should also complete the bottom section 
of the form (yellow). 
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In the case of a prescription for Methadone or Buprenorphine/Naloxone, which is being issued 
for or in connection with the treatment of opioid dependence, the prescription shall not be 
issued unless: 
 The person for whom it is issued is the holder of a valid Opioid Substitution treatment 
card 
 And 
 The prescription is written on a dedicated form required for use under the scheme. 
In the case of a prescription for Methadone or Buprenorphine/Naloxone, which is being issued 
for the treatment of a person for the purposes other than for or in connection with opioid 
dependence, the prescription shall not be issued unless: 
 The prescription has been issued by a medical consultant (in hospital practice) or has 
been initiated by such consultant, whose name and address must be included on the 
prescription 
And 
 The prescription is written on a dedicated form required for use under the scheme. 
In all cases the practitioner must be satisfied as to the identity of the person for whose 
treatment the prescription is being issued. 
Pharmacists are equally obliged not to supply Methadone or Buprenorphine/Naloxone to any 
person unless the procedures and requirements outlined above are fully complied with. 
Pharmacist should also be satisfied as to the identity of the person for whose treatment the 
prescription has been issued and that the person in the event of opioid dependence is on the 
Central Treatment List and the pharmacy has been issued with a valid drug treatment card. 
The information on the prescription forms must be clearly stated. Information that is 
incomplete, illegible or misleading will present difficulties to the pharmacist in attempting to 
dispense it to the patient, who may urgently require the medication, and to the prescribing 
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3.9.2 Requisitions for Methadone/Suboxone for Professional Use 
 
In certain rare instances, such as in the case of those doctors providing services to persons 
held in Garda stations, it will be necessary for practitioners to obtain supplies of Methadone 
or Buprenorphine/Naloxone for professional use. In those instances, the official prescription 
forms should be used and the words “Requisition ‘For professional use” written in the place 
allocated on these forms for the name and address of the patient. 
Unlike the prescription forms where the top copy (i.e. the original) must be submitted as the 
notification, in the case of requisitions, the carbon copy must be submitted. The top copy of 
the requisition (i.e. the original) must be retained by the pharmacist in order to comply with the 
record keeping requirements of the Misuse of Drugs Regulations, 1988 (S.I. No. 328 of 1988). 
The practitioners must pay for any supplies of Methadone or Buprenorphine/Naloxone 
obtained in this manner. 
 
3.9.3 Hepatitis B Vaccinations – Pharmacy Staff Members 
 
Arrangements are in place to facilitate the provision of a course of Hepatitis B Vaccinations to 
staff in pharmacies registered with the Opioid Substitution Treatment Scheme.  
In order to avail of this facility the staff members must be registered under the Drugs Payment 
Scheme and the Pharmacist must complete a registration form in respect of each eligible staff 
member.  Please note that all fields on the form must be completed in order for the staff 
member to receive the vaccinations. 
Part 1 of the registration form should be sent to  
Contract Support Unit 
HSE-PCERS 
Units 1-5 Ground Floor 
J5 North Park Offices 
North Park Business Park 
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Registration forms should be sent by separate post from monthly claim bundles. It is important 
to note that the GP can only validate eligibility and provide the vaccination to your staff after 
the registration has been received in PCERS. Therefore, the fully completed registration forms 
should be forwarded to PCERS as soon as they are completed. 
Part 2 should be retained by the Pharmacist for your own records. 
Part 3 should be given to the staff member in order that it may be presented to a currently 
registered GMS doctor when attending to receive each vaccination. 
The entire course consists of three vaccinations followed by a serology test, and is completed 
over a period of months.  
If any staff member is the holder of a Medical Card they are entitled to the course of 
vaccinations under the arrangements for patients in at-risk categories and should avail of the 
service in the normal way through the Medical Card scheme. 
 
3.10 Stock Orders 
 
3.10.1 Dispensing Doctors’ Stock Order Forms (White) 
 
The Doctors’ Agreement stipulates that a dispensing doctor shall obtain his/her requirements 
of GMS reimbursable items from a contractor pharmacist whose premises are in the doctor’s 
normal area of practice.  If there are no such premises in that area the doctor is to obtain 
his/her requirements from a reasonably convenient contractor pharmacist. Only GMS 
reimbursable items may be obtained on a Dispensing Doctor’s Stock Order Form. Exempt 
Medicinal Products are not covered by these arrangements 
 
A Dispensing Doctor’s Stock Order Form consists of an original form and three self-carbonised 
copies: 
 Original - the pharmacist’s claim form 
 Copy 1  - for the pharmacist’s records 
 Copy 2  - for the HSE’s records 
 Copy 3  - for the dispensing doctor’s own records 
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A dispensing doctor must submit Stock Order Forms to their Community HSE Office for prior 
approval by the relevant HSE Pharmacist.  All entries in the yellow panels of the original form 
must be duly completed beforehand.  The dispensing doctor detaches Copy 3 from each Stock 
Order Form before forwarding the original with Copies 1 and 2 attached to their Community 
HSE Office.   
Stock Order Forms should be submitted at monthly intervals.  Following approval the 
Community HSE Office will forward the original and Copy 1 of the Stock Order Form to the 
pharmacist nominated by the dispensing doctor. Pharmacists should not supply on the basis 
of unauthorized stock order forms to GP surgeries. 
 
3.10.2  Completion of Stock Order Forms – Yellow Panels 
 
In the appropriate yellow panels, Doctors must  
 enter the name and address of the pharmacy  
 write or stamp their own name and address on the original copies  
 write their signature 
 enter their contract number in the space provided  
 insert the date on which the Stock Order was issued and  
 clearly indicate in columns 1 and 2 the size, strength and quantity of the item(s) 
required. 
 
3.10.3 Receipt of Stock Order Items from Pharmacy – Completion of Blue 
Panel 
 
The Declaration at the foot of each Stock Order Form regarding receipt of stock items should 
not be signed and dated until doctors have checked the stock received (entered in column 3 
– blue panel) against what was ordered (entered in columns 1 and 2 – yellow panel).  Any 
discrepancies, such as items ordered but not supplied or supplied in part only should be 
identified at that stage.  There should also be a check of the expiry dates of drugs received 
with a minimum shelf life of twelve months. 
To enable pharmacists to prepare their claims for submission to the Primary Care Eligibility & 
Reimbursement Service it is required that supplies obtained on Stock Order Forms within any 
month would be checked and signed for before month end. 
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3.10.4  Quantity of Stock Held 
 
Medicines, drugs and appliances should only be supplied to a dispensing doctor on receipt of 
a stock order form fully completed by her/him that has received prior approval from the 
Community HSE Pharmacist.   
 
Pharmacists should note that they are responsible for ensuring that the stock items supplied 
are of the description, specification and quantity as set out in the Stock Order Form and that 
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they are well within expiry date (with a minimum shelf life of twelve months), undamaged and 
otherwise of a quality and condition suitable for use. 
 
 
3.10.5  Order Forms for Syringes, Needles and Dressings (Pink) 
 
The Order Form should be used by all participating doctors to obtain supplies of Non-Insulin 
Disposable Syringes and Needles combined or separate.  Dressings for use by doctors in their 
surgeries in respect of their GMS patients should be ordered on the Order Form from the list 
of Dressings reimbursable under the Scheme (PCRS Online Service > List of Reimbursable 
Items). 
Order Forms must have the following entries completed before being given to a pharmacist.  
Doctors must  
 have the name and address of the pharmacy entered in the space provided  
 write or stamp their own name and address on the original and copy  
 write their signature  
 enter their computer sequence number in the space provided  
 insert the date on which the special order form is issued and  
 clearly indicate in columns 1 and 2 the size and quantity of the item(s) required. 
 
The Declaration at the foot of each Order Form regarding receipt of stock items should not be 
signed and dated until doctors have checked the stock received (and completed column 3 – 
Quantity received) against what was ordered so that any discrepancies, such as items ordered 
but not supplied or supplied in part only, are identified at that stage. 
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3.10.6  Termination of Pregnancy Service (Blue) 
 
Termination of Pregnancy (ToP) Services in the community setting were commenced by the 
HSE on the 1st January 2019. The medicinal products, Mifepristone and Misoprostol are 
available to order by approved providers (GPs and designated centres) through the Stock 
Order system from Community Pharmacies. Approved providers are provided with the blue 
stock order form. It is essential that the quantities ordered are in line with the expectation of 
service needs at the medical practice.  
Initial pharmacy authorisation by the HSE to access stock from the supplier can take a 
maximum of 48 hours. This is a once-off process and the pharmacy will be authorised to obtain 
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stocks of product thereafter. Pharmacies notify the HSE by forwarding the scanned copy of 
the blue stock order forms to pharmacy.response@hse.ie. 
It is important that Stock Order Forms are completed correctly. The following must be in the 
spaces provided: 
• The name and address of the pharmacy,  
• The Doctor’s name and address and GMS contract number or Clinic identifier, 
• His/her signature, written in ink, 
• The date on which s/he wrote the stock order, 
• List the stock item(s), strength and quantity of the item(s) required. Quantities should 
correspond to the pack size of the product and be such that they fulfil the service 
requirement in the surgery at that time. 
• The administrative code for each product supplied. Each line of a stock order form 
should be coded and only one item must be entered on each stock order line. 
 The dispensing Doctor must at a later date sign and date the stock order form certifying 
that s/he has received the stock item(s) as ordered. 
The top copy of the Stock Order Form should be submitted to PCERS for reimbursement and 
claimed as a ‘Pink Stock Order Form’ with invoice attached at the end of the month.  
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4. Reimbursement Arrangements  
The PCERS maintains lists of items for which contractors are reimbursed in accordance with 
GMS and Community Drug Schemes. Lists of these items and the reimbursement price can 
be displayed and downloaded from the PCERS website at www.pcrs.ie > List of Reimbursable 
Items. Contractors should continue to refer to existing information sources for definitive rules 
regarding prescribing / dispensing eligibility. 
A code number of five figures is assigned to a specific pack of each product or standard 
preparation. When this number is submitted electronically for payment it will identify the 
product or preparation dispensed and the pack from which it was dispensed. The quantity 
dispensed must also be indicated and correspond to the prescription.  
 
4.1   Extemporaneous Preparations 
 
4.1.1. General Medical Services Scheme Extemporaneous Preparations 
 
For GMS extemporaneous preparations electronically submitted; the relevant code should be 
transmitted along with a description of the preparation, formula used, the quantity dispensed 
and the ingredient cost as per the Health Professionals (Reduction of Payments to Community 
Pharmacy Contractors) Regulations 2013. The claiming code will trigger the relevant 






99159 Oral Medication €6.53 
99160 Compounding of Dispensing Powders €19.60 
99161 Compounding of Ointments or Creams €13.07 
 
 
4.1.2 Community Drug Schemes Extemporaneous Preparations 
 
For DPS/LTI/HAA extemporaneous preparations electronically submitted; the relevant code 
should be transmitted along with a description of the preparation, formula used, the quantity 
dispensed and the ingredient cost as per the Health Professionals (Reduction of Payments to 
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Community Pharmacy Contractors) Regulations 2013. The claiming code will trigger the 






99166 Eye drops €13.68 




99168 Up to 100 ml €10.94 
99169 101 ml to 200 ml €14.97 
99170 201 ml to 300 ml €17.04 




99173 Up to 100 ml €10.89 
99174 101 ml to 200 ml €15.24 
99175 201 ml to 300 ml €17.12 
99176 301 ml and over €22.74 
 
Ointments and Creams 
 
99177 Up to 30 g €13.76 
99178 31 g to 60 g €18.64 
99180 61 g to 120 g €23.97 
99181 121 g to 240 g €28.90 




99183 Up to 20 sachets €20.44 
99184 Thereafter per 20 sachets (pro rata) €12.26 
 
 
Extemporaneous codes must not be used for preparations that are coded and on the 
Reimbursement List, even though at times they may have to be prepared extemporaneously, 
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4.2 Non GMS Listed Ostomy and Urinary Products, Incontinence Products, 
Infertility Drugs, and Unauthorised Medicines  
 
Non GMS (i.e. DPS / LTI / HAA) listed Ostomy and Urinary Products, Incontinence Products, 
Infertility Drugs and Unauthorised Medicines should be submitted as exceptions with copy 
invoice attached and coded as follows: 
 
Ostomy/Urinary to pay 1 fee VAT Code 1 (0%)  77770 
 
to pay 1 fee VAT Code 3 (23%)  77771 
Dressings to pay 1 fee VAT Code 3 (23%)  77720 
Incontinence Products to pay 1 fee VAT Code 1 (0%)  77730 
 
to pay 1 fee VAT Code 2 (23%)  77731 
 
to pay 1 fee VAT Code 3 (23%)  77732 
Infertility Drugs to pay 1 fee VAT Code 1 (0%)    77740 
 to pay 1 fee VAT Code 3 (23%)  77741 
Unauthorised Medicines to pay 1 fee VAT Code 1 (0%)  77750 
 
to pay 1 fee VAT Code 3 (23%)  77751 
Food Supplement Products to pay 1 fee VAT Code 2 (13.5%) 77752 
*VAT rates are correct as of January 2020 
Where a Pharmacist wishes to claim in respect of one of these circumstances s/he will use 
the appropriate code and insert the quantity dispensed in the quantity field.  
N.B. In addition the exact quantity of each item supplied must be specified in writing for 
clarification in the Drug Name and Strength panel. 
A copy of the relevant invoice is required and must accompany such claims. In all cases where 
an invoice is not attached, the claim will be rejected for payment.  
 
4.3 Exempt Medicinal Products 
 
Certain Exempt Medicinal Products (EMPs) have been provided with administrative codes. 
Where the coded medicines are prescribed for Medical Card Patients on properly completed 
GMS prescription forms, you can dispense and claim for the products electronically using the 
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codes specified, submitting them in the normal manner with your monthly claims. In addition, 
the list of products with their claiming codes should be used for claims under the DPS and, 
where applicable, LTI and HAA schemes. 
 
You are reminded that EMPs must be Consultant initiated. Pharmacists should document 
which Consultant initiated the therapy and the hospital that the patient attended. The HSE will 
accept a GP prescription where the Dispensing Pharmacist is satisfied that the product has 
been Consultant initiated. 
 
Doctors and Pharmacists must ensure that the usage of EMPs is minimised to those situations 
where no suitable licensed alternative is available for the patient and should recognise the 
importance of using a licensed alternative where possible. Where an EMP needs to be 
prescribed, the Doctor and Pharmacist are asked to ensure the patient understands that their 
medicine is not licensed in Ireland. 
The protocol for Supply of Exempt Medicinal Products (EMPs) under the GMS and Community 
Drugs Schemes is as follows: 
a) The medicinal product concerned should be an 'allopathic' medicinal product which 
has been industrially produced and which is appropriate for use in the Community  
b) The medicinal product concerned should be such that no authorised medicinal product 
of essential similarity is available for prescription and supply under the Community 
Drug Scheme concerned 
c) The prescription concerned should be written or initiated by a medical consultant who 
is aware of the unauthorised status of the medicinal product concerned and who has 
informed the patient of the situation 
d) The dispensing Pharmacist has also informed the patient of the unauthorised status of 
the medicinal product prescribed and that its quality, safety and efficacy has not been 
established in this country  
e) The medicinal product concerned is not being advertised or promoted in the State 
either as such or in any trade catalogue or price list in circulation in the State 
f) The application made for reimbursement is accompanied by a copy of the invoice in 
relating to the supply of the medicinal product to the Pharmacist concerned and, if 
necessary, is supported by an explanation of the special circumstances which required 
the supply of the unauthorised medicinal product  
g) The medicinal product concerned has been written on a prescription form as the only 
item on the form 
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h) The cost of the medicinal product concerned should be reasonable in the context of 
medicinal products ordinarily supplied and used in the Community and be of a category 
which, if it were authorised, would be eligible for reimbursement in the Community Drug 
Scheme concerned 
i) The original prescription or a copy thereof, together with appropriate records of supply, 
is retained in the pharmacy and kept available for inspection as required. 
 
Please note that EMPs not coded, where prescribed for a person with GMS eligibility by a 
Hospital Consultant, will require individual approval at local level and subsequent submission 
to that office for payment under the Discretionary Hardship Arrangements.  
 
Approval should be sought via PCERS for EMPs not coded to ensure that payment will be 
authorised through exceptional (‘777’) arrangements under Community Drug Schemes 
(section 4.2). Novel items will require completion of an Individual Reimbursement Application 
Form (Appendix) by the hospital prescriber for consideration of reimbursement support.      
 
Exempt Medicinal Products prescribed in Ireland will be subject to an ongoing clinical and 
pricing review with due diligence regarding the unmet clinical need. Communication will be 
issued to Pharmacists where additions, changes and deletions are applied. 
If you have any queries in relation to EMPs, please contact PCRS.ExemptMed@hse.ie.  
 
 
4.4   Phased Dispensing 
There are a number of reasons previously agreed as appropriate for claiming phased 
dispensing fees. 
1. At the request of a patient's physician; 
2. Due to the inherent nature of a medicinal product i.e. product 
stability and shelf life; 
3. Where a patient is commencing new drug therapy with a view to 
establishing patient tolerance and acceptability before continuing on 
a full treatment regime; 
4. In exceptional circumstances where the patient is incapable of 
safely and effectively managing the medication regimen  
 
Since 1st May 2017, prior approval for ‘phased dispensing’ claims are necessary for 
subsequent reimbursement claims to be paid under Reasons 1 and 4. 
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Prior approval is not required under Reasons 2 and 3, which are very occasional and specific 
in nature. The rate of such claims continue to be monitored and can be added to the 
arrangements if necessary. 
 
Phased Dispensing Approval Request screens are available on the Pharmacy Application 
Suite for completion. For phased dispensing fees to be payable, Pharmacy users must first 
enter a valid Medical Card Number and identify either Reason 1 or Reason 4 as the reason 
that the patient requires a phased dispensing service. This must be done prior to providing a 
phased dispensing service to the patient. 
 
Where the GP has made a request to the dispensing pharmacy by inserting the words 
‘phased dispensing’ on the face of the prescription, Reason 1 should be chosen, with a copy 
of the GP prescription displaying the doctor’s instruction for phased dispensing scanned or 
photographed and attached on the application suite before submission. 
 
In exceptional circumstances where the patient is incapable of safely and effectively managing 
their medication regimen, it remains available for the Pharmacist to make that determination 
as a sole practitioner. However, in those circumstances where the Pharmacist has assessed 
the patient risk and made the determination that exceptional circumstances apply, Reason 4 
must be chosen. Where the following criteria can be confirmed, it is highly likely that the patient 
will be approved in a very short timeframe: 
 Patient is over 80 years 
 Patient is on one or more psychotropic medicines (with the 5 digit codes of the relevant 
medicines provided) 
 Patient is on 5 or more oral medicines in a month. 
 PSI Registration of Pharmacist conducting the assessment 
 Date of Pharmacist assessment of patient 
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If one or more of the above confirmations cannot be provided, the application will require 
further assessment and it may be 24 hours (Monday to Friday, or the first working day after a 
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weekend) before approval or non-approval will be communicated back to the pharmacy by the 
PCERS through the application suite. While the application is under consideration, ‘pending’ 
will be displayed on the screen. 
 
If an application for a phased dispensing service is ‘Not Approved’, and the Pharmacist wishes 
to appeal the HSE decision in this regard, an appeal can be registered by the Pharmacist by 
providing additional information on the patient’s particular circumstances to the HSE 
Pharmacist in whose operational area of responsibility the pharmacy is located.  
 
It is important for audit purposes that supporting documentation can be provided to the HSE 
on request or during inspections to substantiate such supply to include the dates of each 
multiple supply occasion. 
 
 
4.4.1 Monitored Dosage Systems / Blister Packing 
 
It is important to note that Monitored Dosage Systems (MDS) / blister packing and phased 
dispensing are two separate processes. Phased Dispensing requires the patient to present to 
the pharmacy on multiple occasions in the month e.g. each week for dispensing of medicines 
whereas blister packing is where the medication is given in one visit and is packaged to 
indicate when medication should be taken. MDS / blister packing are not reimbursable 
services by the HSE.  
 
 
4.4.2 Phased Dispensing on Other Schemes 
 
By express statutory provision, phased dispensing has been confined to the GMS Scheme by 
The Health Professionals (Reduction of Payments to Community Pharmacy Contractors) 
Regulations, 2013.  
 
 
4.4.3 Patients Residing in Nursing Homes 
 
You are reminded that where nursing supervision is available in a patient’s residential setting, 
phased dispensing claims should not be submitted but in any event, will not be reimbursed. 
Some claims are presented as four separate prescriptions each for one week’s supply. It 
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remains our position that such attempted circumvention of the HSE’s previously stated policy 
regarding nursing home patients is not acceptable for reimbursement.  
 
Frequently asked questions regarding Phased Dispensing are available in Circular 016/17.  
 
 
4.5  Balance of Stock on Hand 
 
Where, in order to meet the requirements of an expensive prescription, a contractor is obliged 
to purchase a larger quantity than prescribed and where a portion of that pack remains on 
hand after an agreed period, the full cost of the balance of the pack will be paid to the 
contractor. To comply with this regulation the cost of the balance of the pack must be in excess 
of €12.70 and must not have been dispensed within three months prior to the claim being 
made, unless circumstances warrant otherwise, such as dated products expiring within the 
time period.   
The pharmacist should produce the pharmacy copy of the relevant prescription, endorsed with 
the balance of stock on hand and the value of the claim, and the relevant invoice to the 
Community HSE Office, who will in turn forward the documentation to the Primary Care 
Eligibility & Reimbursement Service for processing.  
 
4.6  Monthly Quantities under the Drugs Payment Scheme 
 
The packaging of some drugs and medicines in ’28 days’ packs appears to be causing 
difficulties for some Pharmacists when dispensing under the Drugs Payment Scheme.  It is a 
condition of the scheme that no individual or family grouping will pay more than relevant co-
payment as set out in Regulations, (i.e. co-payment x 12 in a full year).  A second co-payment 
(in the same pharmacy) should only arise when a person is intentionally getting the next 
month’s supply on the grounds that he/she will be away the following month or for other such 
reason. To ensure that an individual or family who are dispensed 28 days’ supply each month 
make no more than 12 payments in a year, once in a 12-month period or periodically 
throughout the year a further 28-day supply can be given. The packaging will influence how 
this can be achieved. Quantities dispensed should correspond with the valid prescription 
recognising that clause 4(2) of the Community Pharmacy Contractor Agreement allows for 
professional judgement and discretion.   
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4.7 Special Drug Requests 
 
Due to the budget impact associated with certain medicine, PCERS introduced a 
reimbursement application system. The following medicines require prior-approval to be in 
place before reimbursement status is granted; 
 
Product Who can submit the application? 




The physician responsible for the 
management of the patient’s 
anticoagulation 
Fampridine (Fampyra®) Consultant Neurologist 
Additional Blood Glucose Test Strips Hospital (Consultant Endocrinologist 
or Diabetic Nurse Specialist) or GP 
Lidocaine 5% Medicated Plaster (Versatis®) Hospital Clinician or GP 
Valsartan/Sacubitril (Entresto®) The physician responsible for the 
initiation of treatment 
FreeStyle Libre (Flash Glucose Monitoring) Sensor Consultant Endocrinologist 
Non-first line Standard Oral Nutritional Supplements Hospital (Doctor or Dietician), HSE 
Dietician or GP 
PrEP (Pre-exposure Prophylaxis) PrEP prescriber approved by the HSE 
Sexual Health Programme 
 
Approval can be confirmed through the ‘Secure Scheme Checker’ under ‘Patient Specific 
Arrangements’. Pharmacies can dispense and claim for the approved item electronically using 
the administrative code for the product, submitting in the normal manner with monthly claims. 
Claims submitted for patients who are not approved will not be paid. 
 
4.8 Tuberculosis (TB) Medication 
 
In line with the Infectious Diseases Regulations 1981, medication for Notifiable Diseases such 
as TB are provided free of charge regardless of scheme. Community pharmacies can submit 
their claims to the relevant Local Health Office (LHO), which then submits the request to 
PCERS using screens at local level. The PPSN is not necessary. Some medicinal products, 
for example Rifater (rifampicin, pyrazinamide and isoniazid) are already GMS reimbursable 
and can be claimed in the normal manner under GMS and Community Drug Schemes. Other 
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drugs such as Ethambutol are provided with administrative codes under the Exempt Medicinal 
Products (EMP) List.  
 
4.9  Third Party Verification  
 
The person receiving the dispensed items under GMS and Community Drug Schemes should 
acknowledge receipt of the supply of the medications listed, on the dispensing date as 
stamped by the pharmacist on the form. The person signs the GMS Prescription or the Unified 
Claim Form in the section provided. There is no requirement to provide a copy of the signed 
GMS prescription form to the patient. 
 
When a person other than the named person on the prescription is collecting their medicines, 
the patient’s nominee should sign the GMS prescription or the Unified Claim Form and the 
relationship of that person to the named person on the prescription should also be recorded 
in the space provided. 
 
4.9.1 Emergency Supply 
 
Where it is necessary to invoke the emergency provisions of the Prescription legislation, the 
Pharmacist can annotate on the claim that it relates to an emergency supply. The number of 
occurrences of emergency supply should be low if the requirements of the relevant legislation 
is respected. 
 
4.9.2 Relationship of Person Collecting  
 
The pharmacist should be satisfied that the person collecting medication on behalf of a patient 
is acting on behalf of the patient. The relationship of the person collecting the medication could 
reflect that they are a relative; carer; neighbour; friend; partner etc. There is no minimum age 
specified in the Regulation of Retail Pharmacy Businesses Regulations 2008 or PSI guidelines 
at which a person can collect a prescription-only medicine either for themselves or on behalf 
of someone else, where they have been given authority to do so. However, the pharmacist 
has a professional and legal responsibility to ensure that medicines are supplied safely from 
a pharmacy to the relevant patient along with sufficient information on how to take the 
medicine safely and as prescribed, and that they know how to store the medicine. The 
Pharmacist must be satisfied that the person collecting the medicine has been authorised to 
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do so by the patient and is of a sufficient age and maturity to safely deliver the medicine to the 
patient with any relevant information. 
 
 
4.9.3 Nursing Home GMS Residents 
 
On admission to a nursing home, patients are normally asked to give consent for the supply 
of their medication from a named pharmacy. The HSE / PCERS will accept the signature of 
the person in charge of a nursing home or their nominated staff member to sign and 
acknowledge receipt of the medication listed, on the dispensing date as stamped by the 
pharmacist on the form. 
 
4.9.4 Literacy Challenges 
 
Literacy challenges arise in a number of circumstances for patients in their interaction with the 
health services. The following provisions apply for patients who are applicants for state 
schemes and these are acceptable for third party verification: 
 The signature can be considered verified where the patient signs their name; 
 The patient may nominate an advocate to act on their behalf and in this situation the 
advocate signs; 
 A patient wishing to represent themselves may place their ‘mark’ on the space for 
signature. 
This may be witnessed by a person who signs and dates the form. 
 
It should be possible for pharmacists to secure a signature in the majority of instances. The 
HSE/PCERS will reimburse pharmacists who dispense prescribed medicines in good faith to 
eligible patients, and who have made reasonable efforts to obtain signatures from the patients 
and/or their representatives. 
 
Please note that it is a requirement by the HSE under Community Schemes that third party 
verification is received, and third party verification is required in order to properly present a 
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4.10 Data Protection 
 
The General Data Protection Regulation (EU) 2016/679 (GDPR) and the Data Protection Act 
2018  oblige the HSE to put in place a data processor agreement, to cover those specific 
circumstances when activities undertaken, under your contract with the HSE, constitute data 
processing on behalf of the HSE. 
 
The Data Processor Agreement is visible on the Pharmacy Application Suite and you must 
confirm acceptance of the agreement for continuing access to the Pharmacy Application Suite.  
 
Data protection breaches, relating to data under the control of the HSE must be notified, 
without delay to: PCRS.DataProtetion@hse.ie.  
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5. Prescription Information  
5.1   Prescription Forms and Dispensing Requirements 
 
Prescription forms must be completed in a clear and legible manner.  Each Form must be 
dated and bear the name, address and valid medical card number of the patient.  Name, 
strength, quantity and dosage of the preparation to be supplied must be clearly shown.  Each 
form must bear the name, address and full signature of the prescribing doctor.  Doctors should 
use their own personalised GMS prescription forms when prescribing for eligible patients of 
their partners or colleagues.  The computer number of the doctor, shown in the space at the 
top right-hand corner of the prescription form, must not be obscured or obliterated.  Incomplete 
or incorrect prescription forms may be rejected for payment to the pharmacist. 
 
Prescriptions, whether for controlled preparations or otherwise, must conform to all legal 
requirements.  Where any drug or preparation, the use of which is controlled by the Misuse of 
Drugs Regulations 1988 and 1993, is prescribed, the prescriber must comply with the 
requirements of Article 13 of the 1988 Regulations on the issuing of prescriptions for such 
drug or preparation.  A prescription for items subject to the Medical Preparations (Prescription 
and Control of Supply) Regulations, 2003 (S.I. No. 540 of 2003) is required to “be in ink and 
be signed by the person issuing it with his usual signature and be dated by him.” 
The prescriber must sign and date alterations and additions. 
Where a prescription is incomplete, in that the prescriber has omitted one of the following: the 
quantity to be dispensed or the strength to be supplied where more than one strength is 
available or the dosage instructions from the prescription the prescriber should be contacted 
where this is possible and the prescription dispensed as follows:- 
Where the prescriber can be contacted – the prescription should be dispensed in accordance 
with the prescriber’s wishes and the missing details inserted by the prescriber and signed by 
him/her. 
Should it not be practicable to have the missing details inserted by the prescriber, the 
pharmacist may with the agreement of the prescriber, add the relevant details required, initial 
and date the endorsement, and indicate that the prescriber was contacted – PC (Prescriber 
Contacted). 
Where the prescriber cannot be contacted: If the pharmacist has sufficient information to make 
a professional judgment s/he may dispense a sufficient quantity of the preparation for up to 7 
days treatment depending on the nature of the prescribed item. Where, from experience of 
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the patient’s previous requirements the Pharmacist is satisfied that a greater quantity is 
justified s/he may dispense up to one month’s supply. The Pharmacist should then: - Add the 
relevant details required, Initial and date the endorsement, and Indicate that the Prescriber 
could not be contacted – PNC (Prescriber Not Contacted). 
It must be emphasised that a claim should not be made where the prescription related to the 
claim is not submitted. Neither is it appropriate to add items to a prescription, even when it 
has been previously dispensed for the patient. Where claims have been paid and the relevant 
prescriptions have not been submitted and these matters come to light through post 
processing reviews or inspections, such monies will be automatically recouped. Such 
behaviour by a contractor may be found to constitute a fraudulent claim against the HSE. 
Where the prescription is typed, the PCERS may not reimburse for items that are handwritten 
onto the prescription unless they are countersigned in the prescribers own handwriting. Where 
there is an unauthorised addition of an item (s), it will not be paid i.e. the addition of an item 
as opposed to a change in the strength / quantity of an item. 
 
5.2   Community Registered Nurse Prescribers 
 
Nurses and midwives can be authorised to prescribe medicinal products. The Irish Medicines 
Board (Miscellaneous Provisions) Act 2006 provided for amendment to the definition of 
practitioner for the purposes of nurse and midwife prescribing. Under the Nurses and Midwives 
Act 2011, the Nurses Rules, 2010 continue to have force as a statutory source of prescriptive 
authority: the Nurses and Midwives Rules, 2013 are supplemental to the Nurses Rules, 2010. 
The legislation allows registered nurses or midwives who have:  
1 Completed an approved education programme;  
2 Appropriate clinical experience;  
3 Registered with An Bord Altranais (Irish Nursing Board) as a Registered Nurse 
Prescriber (RNP);  
4 Authority from the health service provider who employs them to prescribe a range of 
medications within their scope of practice. 
 Personalised GMS Prescription Forms should be completed in the usual manner. 
The Community RNP is issued with a Primary Care Prescription Pad in book format with an 
original and three copies with a facility to record the RNP’s Professional Identification Number 
(PIN): 
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 Original – for presentation by the patient to the pharmacist 
 Copy 1 – for the pharmacist records 
 Copy 2 – for the GP records 
 Copy 3 – for inclusion in the patients clinical notes maintained by the RNP 
 
RNPs employed in: acute/specialist hospitals; mental health services; private hospitals; 
private nursing homes and general practice will not be issued with Primary Care Prescription 
Pads. 
 
5.2.1 Prescribing of Controlled Drugs 
 
Your attention is drawn to the particular restrictions on RNPs prescribing controlled drugs 
(Schedules 2 and 3), details of which are set out in the Misuse of Drugs (Amendment) 
Regulations 2007. This can be accessed inter alia on the Pharmaceutical Society of Ireland 
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Website, at www.thepsi.ie and alternatively on www.irishstatuebook.ie. It should be noted that 
RNPs are not authorised to prescribe methadone. 
 
5.2.2 Prescribing and Dispensing Requirements 
 
With regard to these prescriptions, the Misuse of Drugs Regulations, 2017 and the Medicinal 
Products (Prescription and Control of Supply) Regulations, 2003 and amendments apply in 
full. 
1. Medicinal preparations containing a drug which is the subject of an entry in Schedule 
1A of the Medicinal Products (Prescription and Control of Supply) Regulations, 2003 
are not repeatable unless the doctor explicitly specifies in writing, “Repeat (once or 
twice)”. 
Prescriptions for Schedule 1A (S1A) Drugs which are not specifically so indicated cannot 
be repeated.  Preparations containing or consisting of the following are among those 
covered by Schedule 1A: antibiotics, antidepressants and hypnotic drugs. 
 
2. Controlled drugs in Schedules 2 and 3 of the Misuse of Drugs Regulations should not 
be written on, or dispensed on foot of, a repeat prescription under any circumstances. 
 
 
5.3   Authentication of Prescriptions 
 
There have been several instances when medicines were supplied in good faith on foot of 
GMS prescription forms where such forms were either, duly issued by a doctor and altered 
with intent to deceive, or, stolen from a doctor and issued with fraudulent intent by a person 
without authority to prescribe.  
If any irregularity is suspected, pharmacists have the obligation and the entitlement to make 
enquiry of the person presenting the prescription.  Pharmacist should satisfy themselves 
regarding the bona fides of persons presenting prescriptions (including GMS and other 
prescription forms) which have been issued, or purport to have been issued, by doctors in 
areas far removed from the pharmacists’ own Community. 
GMS panel doctors have been informed to report stolen GMS prescriptions/pads to the Gardaí 
as soon as possible. Once reported to the Gardaí GPs should report the incident to the 
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Business Performance Unit at the Primary Care Reimbursement Service or email 
StolenRX@hse.ie. The HSE will then contact local Pharmacies in the area.  
The Primary Care Reimbursement Service can only accept for payment prescriptions that 
have been signed in full by the doctor in ink.  
 
5.4   Unsigned GMS Prescription Forms 
 
Unsigned GMS prescription forms submitted to the Primary Care Eligibility & Reimbursement 
Service will not be paid and will report on the Detailed Payment Listing, with the message 
“Form not signed by doctor”. 
The procedure for reclaiming payment in respect of items dispensed on unsigned forms is as 
follows. 
 
 In the case of prescriptions for S1A and S1B medicines, the corresponding pharmacy 
copy should be signed by the prescriber and submitted for payment. 
 
 For Schedule 2, Schedule 3 and Schedule 4 Part 1 controlled drugs a standard GMS 
prescription form, written and signed by the prescriber in accordance with the 
requirements of the Misuse of Drugs Regulations, should be marked ‘DUPLICATE’ 
and submitted for payment together with the relevant Reclaim Listing. The 
pharmacist’s Sequence Number of the original form should be shown on the 
replacement form. 
 
 Pharmacists should not accept prescriptions which are not written in compliance with 
Regulation 15 of the Misuse of Drugs Regulations 2017. There is no entitlement to 
payment for prescriptions which do not comply with legal requirements. Where a 
pharmacist suspects that a Medical Practitioner is abusing controlled drugs, the 
Medical Practitioner should be reported to the HSE and should co-operate with the 
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5.5    Illegible Patient Numbers on GMS Prescription Forms 
 
Prescription forms that have ‘illegible’ numbers in the patient number area make identification 
of such claims in a reject situation almost impossible.  The majority of claims containing 
‘illegible’ patient numbers arise on ‘Repeat’ forms.  The incidence of Repeat Prescription 
Forms with illegible patient numbers could be reduced if pharmacists, when dispensing Part 1 
or 2 of a Repeat Prescription Set, ensured that the carbonised entries in the Patient Number 
area are legible and that the patient number corresponds with the Patient Number on the 
original prescription form (Part 3). If necessary the Patient Number could be written on Part 1 
or Part 2 by the pharmacist in a manner that would not obscure details entered by the doctor. 
The use of any erroneous card numbers in the absence of a valid card number will not be 
accepted for payment.          
            
5.6   Carbonised or Copied Prescriptions 
                                         
Prescriptions that have been carbonised or copied from one GMS prescription form onto 
another GMS prescription form, apart from possible legal implications, do not meet Primary 
Care Eligibility & Reimbursement Service requirements and should not be dispensed.  Post-
dated prescription forms should be dispensed only in accordance with the doctor’s instructions 
and submitted for payment to the Primary Care Eligibility & Reimbursement Service in the 
appropriate processing month. 
The Primary Care Eligibility & Reimbursement Service may raise particular instances with the 
health professionals concerned. 
Submitting Supporting Documentation at Month End: 
 All prescriptions should be date stamped with the date of dispensing and must be 
within six months of the date of prescribing (other than controlled drugs which must 
be dispensed within 14 days of prescribing). 
 
 The person collecting the dispensed items must sign for receipt of same in the 
space provided on the claim form. When a person other than the person named on 
the prescription is collecting drugs/medicines under this arrangement the 
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relationship of such person to the GMS named person should be recorded on the 
form.  
 
 All paperwork must be submitted in form number order. 
 
 In instances where there is no supporting paperwork, the value of these claims 
may be recouped. 
 
 The Summary Form must be completed accurately in respect of all schemes. 
 
 
5.7   Incomplete GMS Prescription/Stock Order Forms 
 
Pharmacists are obliged to supply medicines and appliances on foot of a properly completed 
prescription or stock order form in accordance with the terms and conditions of the 
pharmacist’s Agreement with the HSE. 
The Primary Care Eligibility & Reimbursement Service has the obligation in calculating and 
making payments to verify the accuracy and reasonableness of claims and accordingly has 
the right to seek clarification or to require that a prescription form or stock order form be 
returned to the prescribing or dispensing doctor for completion and/or clarification as a 
prerequisite to payment. 
Where a prescription presented to a pharmacist is incomplete, in that the prescriber has 
omitted one of the following: 
 
 the quantity to be dispensed or 
 the strength to be supplied where more than one strength is available or 
 the dosage instructions from the prescription 
 
Where possible the prescriber should be contacted and the prescription dispensed as follows:  
 
1. Where the prescriber can be contacted: 
The prescription should be dispensed in accordance with the prescriber’s wishes and the 
missing details inserted by the prescriber and countersigned by him/her.  Should it not be 
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practicable to have the missing details inserted by the prescriber, the pharmacist may with the 
agreement of the prescriber:  
 
 Add the relevant details required. 
 
 Initial and date the endorsement, and 
 
 Indicate that the prescriber was contacted – P.C. (Prescriber Contacted). 
 
2. Where the prescriber cannot be contacted: 
 If the pharmacist has sufficient information to make a professional judgement s/he may 
dispense a sufficient quantity of the preparation for up to seven days treatment depending on 
the nature of the prescribed item.  Where, from experience of the patient’s previous 
requirements the pharmacist is satisfied that a greater quantity is justified s/he may dispense 
up to one month’s supply.  However the smallest pack quantity must be dispensed in the case 
of combination packs (i.e. packs containing more than one medicinal product) and medicinal 
products for which pharmaceutical considerations dictate supply in the original unopened 
container.   The pharmacist should then:  
 Add the relevant details required. 
 
 Initial and date the endorsement, and 
 
 Indicate that the prescriber could not be contacted – P.N.C. (Prescriber not 
Contacted). 
 
In the interest of patient care it is required that the pharmacist should subsequently inform the 
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5.8   Compliance with Statutory Requirements 
 
A Controlled Drug may not be dispensed unless the appropriate statutory requirements are 
met.  The Primary Care Reimbursement Service reserves the right to bring to the attention of 
the appropriate authorities serious breaches of statutory requirements that come to its notice. 
 
5.9   Pack Sizes 
 
 Where such terms as small, medium or large are used by the doctor in a prescription 
to indicate the quantity to be supplied, such prescription should be considered as being 
incomplete and dealt with as above or alternatively the smallest pack size should be 
dispensed. 
 
 Where the quantity of a preparation prescribed does not correspond with an original 
pack size and it is not feasible to supply the exact amount prescribed the pharmacist 
may, in the exercise of his professional judgement and bearing in mind the nature of 
the product and his statutory obligations, supply the original pack size nearest to the 




5.10 Dressings and Appliances 
 
 Where the size (but not the quantity) of any dressing has been omitted by the doctor 
from the order form, the most appropriate size should be supplied. 
 
 Where the quantity (but not the size) of dressing has been omitted by the doctor from 
the order form, a single unit/piece/pack of the specified item should be supplied. 
 
 In certain cases, such as ostomy appliances, units should be supplied unopened as 
received from the supplier. 
 
 
5.11 Parallel Imported Products 
 
Each of the parallel imported products on the List of Reimbursable Items has a separate 
unique GMS code number from the originator medicinal product pack.  Where a parallel import 
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is dispensed the pharmacist must ensure that the correct GMS code number is entered on the 
claim form so that the appropriate payment is made. 
 
5.12 Request for the Production of Invoices 
 
From time to time the Primary Care Eligibility & Reimbursement Service requests pharmacists 
to submit copies of relevant invoices to clarify and/or substantiate claims for payment relating 
to items which do not appear to be completely in order for payment.  The Primary Care 
Eligibility & Reimbursement Service has a duty relating to the reasonableness and accuracy 
of payments and may withhold payment until it is satisfied that a claim is correct in every 
respect.  Accordingly, when requested, pharmacists should submit invoices without delay and 
facilitate the correct payment of their claims as soon as possible. Retention of Invoices of 
medicinal products, as records under the Medicinal Products (Prescription and Control of 
Supply Regulations 2003 (as amended), must be held on the premises for a period of two 
years. These records should be readily available for inspection on request. 
When submitting products under ‘777’ arrangements (see section 4.2) an invoice must be 
submitted with the claim.  
 
5.13 Owings Management 
 
Pharmacists should only present a claim for reimbursement by the HSE in respect of items 
which are supplied on foot of a properly completed prescription in accordance with the 
Community Pharmacy Contractor Agreement. 
Circumstances may arise in practice where the full quantity of a prescription item is not filled 
and supplied and, as a result, the pharmacy will temporarily owe their patient a balancing 
quantity. Such a balancing quantity should only be submitted for reimbursement where the 
pharmacist has a genuine expectation that the patient will return in the near future in line with 
Clause 1(1) of the Contractor Agreement to collect the remainder of their prescription, which 
is awaiting collection in the pharmacy. 
Each contractor is encouraged to make arrangements with their software vendor to implement 
transparency regarding their management of owing and ensuring that owings are managed 
appropriately to ensure that invalid claims are not submitted to the PCERS misrepresented as 
supplied to patients. 
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5.14 Non-Dispensing Fee Claim  
 
Pharmacies can claim a fee in respect of the exercise of professional judgment resulting in a 
decision by a pharmacist not to dispense a reimbursable item on foot of a GMS prescription 
form, Pharmacists must use the code 79999 and submit a cogent reason for the non-
dispensing.  
Where it is not clear that the Pharmacist has exercised their professional judgement leading 
to a decision not to dispense a GMS Reimbursable item, the fee will not be paid.     
In circumstances where there is a repeated pattern of Non-Dispensing Fee claims, over 
several months, for the same prescribed items in respect of an individual patient, it would be 
expected that the prescriber be contacted to draw attention to the redundant prescribed items.  
The following reasons specified are not acceptable for payment of the Non-Dispensing Fee; 
 The item is not available i.e. stock shortage or product discontinuation situations, 
 The item is delisted,  
 The item is an owing to the patient or marked as ‘collect later’, 
 Supply is not a lawful option i.e. the prescription is not valid , 
 Supply is not a contractually valid option i.e. Nicotine Replacement Therapy on a GMS 
Repeat Form, 
 Where it has been indicated that the patient is deceased, 
 The item is not required by the Nursing Home,  
 The supply frequency according to the Summary of Product Characteristics is such 
that monthly dispensing’s should not occur e.g. Prolia®, Mirena®, Nebido®, 
Implanon®, Depo-Provera®,  
 Medicines that require prior approval by PCERS and for which the patient has not been 
approved. For example; Entresto®, FreeStyle Libre®, Fampyra®, Xarelto®.  
 The amount of blood glucose test strips dispensed to a patient has reached the 
maximum approved quantity and the Non-Dispensing Fee is requested to be paid for 
not dispensing above the threshold,  
 The patient has purchased the product ‘over the counter’,  
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 The item has been claimed under another scheme i.e. LTI eligibility,  
 A maximum quantity is specified and has been claimed in the same calendar month 
e.g. medication for erectile dysfunction, Victoza®, Zyban®. 
The Non-Dispensing Fee does not apply to stock order forms, as these are not patient specific. 
Additionally, the Non-Dispensing Fee cannot be claimed under the Hospital Emergency 
Scheme. 
Under the GMS Scheme, where a Pharmacist supplies a GMS reimbursable item against a 
properly completed GMS Prescription Form, the appropriate fee will be payable. Where the 
Pharmacist has exercised professional judgement leading to a decision not to dispense a GMS 
reimbursable item, the Non-Dispensing Fee may be claimed.  
 
5.15 Nicotine Replacement Therapies (NRT) 
The Department of Health approved the reimbursement of Nicotine Replacement Therapy 
(NRT) for eligible GMS persons only with effect from the 1st April 2001.  
 The quantity to be prescribed and dispensed on the initial prescription should be limited 
to two weeks supply in order to evaluate the success of the individual therapy  
 NRT must be prescribed on a single GMS form 
 Patients are not limited to a maximum duration of therapy 
 More than one formulation (e.g. NRT patch and chewing gum) may be prescribed as 
per research involving dual support 
 Under community drug schemes reimbursement for NRT is limited to the GMS scheme 
Varenicline and Bupropion, classified as drugs used in nicotine dependence are reimbursable 
under GMS and Drugs Payments Scheme (DPS). PCERS accept claims for combined 
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5.16 Drugs for Erectile Dysfunction 
The Department of Health approved the admission of certain oral dosage forms of drugs used 
in the treatment of erectile dysfunction to the list of reimbursable items on the GMS and 
Community Drug Schemes. To ensure availability for genuine need, but to reduce the 
possibility of inappropriate usage, the maximum reimbursable level for oral dosage forms of 
drugs used in the treatment of erectile dysfunction is a total of four per month. This will apply 
whether or not more than one such oral medicinal product has been prescribed and dispensed 
for a patient in the same calendar month. The Primary Care Reimbursement Service will not 
reimburse quantities in excess of this level. 
On 1st April 2017, the HSE ceased reimbursement of Phosphodiesterase type-5 (PDE5) 
inhibitors for the treatment of erectile dysfunction with the exception of low cost referenced 
priced products.  
This decision applied to both branded and parallel imported products. Formulations 
reimbursed under the High Tech arrangements for other indications (e.g. Pulmonary Arterial 
Hypertension) are not affected.  
 
5.17 Prolia® (Denosumab) 
 
The recommended dose of Prolia is 60 mg administered as a single injection every 6 months. 
Where a claim is submitted in a shorter timeframe than expected for a patient using this 
medication, Pharmacists will see an error message on their detailed payment listings. Where 
this occurs, an automatic mark-down will be applied.  
 
 
5.18 Victoza® (Liraglutide) 
 
The maximum quantity allowed under GMS and Community Drug Schemes is one box of 
Victoza® per month (or a maximum of three pens). Prescriptions for Liraglutide at doses in 
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5.19 Non-Drug Items 
 
Certain non-drug items are available on the Reimbursement List; 
 Clinical Nutritional Products 
 Urinary Products 
 Ostomy Products 
 Wound Management Products 
 Personal Diagnostic, Monitoring and Delivery devices 
The HSE is satisfied that there is a range of non-drug items available to sufficiently cover 
patient requirements in the community setting.  
Whilst Wound Management Products (i.e. Dressings) are not available to patients on GMS 
prescriptions, certain items are provided on the Reimbursement List for GP Stock Orders 
(Pink). Where there are no local arrangements in place to make supplies through the Public 
Health Nurse / Community Health Nurse at local level, applications can be submitted under 
Discretionary Hardship Arrangements for approval supported by a GP prescription. 
 
Wound Management Products considered as Normal Nursing Needs that would be expected 
to be available as stock in residential settings will not be reimbursed.  
 
Since January 2018, compression hosiery products have been provided with administrative 
codes. This means that where such products on the Reimbursement List are prescribed, they 
can be dispensed and claimed for electronically. Compression Hosiery will no longer require 
individual authorisation by the Local Health Office under Discretionary Hardship 
Arrangements. Reimbursement support is provided for two pairs per calendar year. Claims 
submitted outside the approved yearly threshold will not be reimbursed. This arrangement 
applies to medical card holders under the GMS scheme only.   
 
 
5.20 Economic Prescribing and Dispensing on the GMS Scheme 
 
Pharmacists should be mindful of their obligations under Clause 9 of the Community 
Pharmacy Contractor Agreement to facilitate the prescribing doctor in establishing the most 
cost effective treatment for a patient.  
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Doctors have been asked for their co-operation in securing whatever economies are possible 
without reducing the effectiveness of the service or affecting the best interests of patients.  
They have been asked to consider, when prescribing, whether there is an equally effective but 
less expensive medicinal product available.   
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6. Submission of Claims  
 
Claims should be submitted on a monthly basis.  The electronic submission of claims is now 
standard and offers the following benefits.   
 Electronic submission and Early Pay of GMS, DPS, LTI, HAA and High Tech claims  
 Integrated electronic correction claims  
 Direct pharmacy to HSE claim submission  
 SMS submission deadline reminders * 
 SMS communication in event of Central Technical Issue at PCERS * 
*To avail of SMS communication e-mail cert.info@hse.ie for a registration form.  
 
6.1    Submission of ‘Early Pay’ 
 
To qualify for early payment, electronic claims must be received by the PCERS no later than 
midnight on the 3rd working day of the month. 
Working days are defined as Monday to Friday, excluding public/bank holidays.  As you submit 
your file, your software should confirm immediately that your file has been received by PCERS.  
If you are unsure if your file has been transmitted correctly a ‘Transmission History’ file is 
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In order to minimise the impact of unforeseen technical difficulties, either with telephone 
connections or technical problems with files or transmission issues, Pharmacists are advised 
to submit their initial claim file on the 1st day of the month. For the fastest processing 
turnaround, avoid peak time queues during working hours.  Where a Pharmacist leaves the 
transmission of their file until the last available day, they run the risk of unforeseen 
transmission issues that may result in their file not being received in the PCERS on time.  
PCERS will not accept files after the deadline for receipt has passed.  In such an event the 
claims will not be processed in the early pay cycle.  Claims submitted electronically and 
received at PCERS after the 3rd working day and by midnight of the 7th day of the month 
will be processed electronically and paid in the normal pay cycle.  
Supporting paperwork must be received by close of business on the 5th of each month.   If 
the deadline falls on the weekend or bank holiday, it moves to the next available working day. 
Paperwork which is received after the close off date or not presented as requested will be put 
to one side and processed as time allows. 
 
6.2    Submission of claims for ‘Normal Pay’ 
 
Electronic claims must be received by the PCERS by midnight on the 7th of each month. 
Paperwork for electronic and manual claims must be received by close of business on the 7th 
day.  If the deadline for paperwork falls on the weekend or bank holiday, it moves to the next 
available working day. 
A schedule of submission dates for early and normal pay cycles is circulated annually. To 
ensure claims are submitted by the due dates it is recommended to place this calendar 
prominently within in your pharmacy. 
Technical issues outside of the control of the PCERS are a matter for the Software vendor or 
the Pharmacist.  PCERS cannot be held responsible for any technical issues that arise outside 
of our direct control.  Pharmacy business should build a contingency into their submission 
schedule to deal with such unforeseeable technical problems that may arise from time to time.  
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6.3    Exception Files 
 
Exception files contain details of rejected claims for your examination, correction and re-
submission.  In the event that the whole file fails to load, the exception file will confirm this fact 
for your attention.  Exception files are available for download no later than 4 working days 
from receipt and in most cases are available within 24 hours.  There is no limit on the number 
of download and re-submission cycles. However, the final submission must be received in the 
PCERS no later than midnight on the 8th working day. 
 
6.4    Submission of Supporting Paperwork 
 
To ensure your claims are processed promptly, ensure the appropriate claim forms for the 
schemes are tagged together with a properly completed Summary of Claims Certificate at the 
top of the bundle. 
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Yellow bags, treasury tags, summary certificates and elastic bands are required to submit your 
supporting paperwork. The address should be clearly visible on the yellow bag and the 
Pharmacy number should be inserted in the box provided. 
 
Within the yellow bag provided submit claims in two separate bundles as follows: 
Bundle 1: GMS Regular, GMS Repeat, Hospital Emergency, Stock Order and Dental Claims 
secured using elastic bands. 
Bundle 2: DPS, LTI, High Tech, HAA and EC Claims secured using elastic bands. 
Please ensure no sharp objects are used to secure the content in the yellow bag(s) as 
staples and other sharp material can present a hazard when opening the bag(s). 
Supporting paperwork which is received after the close off date or not presented as requested 
will be put to one side and processed as time allows. 
 
We have enhanced services available on our Pharmacy Application Suite on www.pcrs.ie to 
enable you to order additional supplies of the following items: 
- Unified Claim Forms 
- GMS Summary Forms 
- DPS Summary Forms 
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- LTI/EEA/HAA Summary Forms 
- Methadone Summary Forms 
- High Tech Summary Forms 
- Treasury Tags 
 




6.5    Change of Contract and Contractor Data Maintenance 
 
Where a pharmacy changes contract mid-month, the PCERS will accept one file per month 
per contract agreement.  The PCERS system will validate claim dates and only pay where the 
contract is valid. 
The following changes need to be routinely notified in writing to the HSE (see circular 
007/18 for further details): 
 Changes in supervising pharmacist 
 Change in beneficial ownership (this results in the termination of the Agreement and 
a new agreement to be signed as per Clause 22 (2)) 
 Change in Directors (where they have signed the SEPA form – a copy of which is 
enclosed for ease of reference. It is important to note that unless these details and 
signatures are kept up to date, monies may not be released if there is a request to 
change bank accounts etc.) 
 Changes to Company Registration Number 
 Changes to the PSI RPB registration number 
 Changes in opening hours (which as per clause 8 of the Contractor Agreement must 
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6.6    Payments 
 
Payment is made by Credit Transfer to the Bank Account most recently identified on the Pay 
Mandate form received by the Primary Care Eligibility & Reimbursement Service.  It is the 
contract holder’s responsibility to keep the Primary Care Eligibility & Reimbursement Service 
advised of the correct bank account details. Occasionally for exceptional reasons PCERS may 
change payment method to cheque. 
 
Where claims qualify for early payment, the bank file is submitted into pharmacy accounts on 
the 15th working day of a month.  
 
Where claims qualify for Normal/manual DPS payment, the bank file is submitted into 
pharmacy accounts between the 5th and the 7th of the following month.  
 
Where claims qualify for Normal/manual GMS payment, the bank file is submitted into 
pharmacy accounts between the 19th and 21st of the following month.  
 
Details of claims paid are reported on a ‘Detailed Payment Listing’ which is available online 
within a week of payment to each pharmacist paid in that month 
 
A Form F45-1 (Withholding Tax Certificate) is also issued, under separate cover, in respect of 
each pharmacist paid in a particular month. 
 
Errors encountered in the processing of data entered on a form will result in the non-payment 
of such claims. These will be reported on a Reject/Reclaim Listing, which form part of the 
monthly Detailed Payment Listing issued by the Primary Care Eligibility & Reimbursement 
Service.   
The reason for the rejection will be given and where applicable the claimant will be asked to 
insert additional/corrected information on the listing/ Pharmacy exception file and return same 
to the Primary Care Eligibility & Reimbursement Service for processing.  
From July 2018 Detailed payment Listings are only available online via the Pharmacy 
Application Suite. In the event a replacement listings is requested a fee of €12.70, per listing, 
is applicable in order to arrange a reprint.  
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Queries should be submitted using the Pharmacy Query Form which is available for download 
on the Pharmacy Application Suite and also at www.pcrs.ie > Online Services > Services for 
Pharmacists Only > Query Form for Pharmacists 
Query Forms may be scanned and sent to our dedicated email address at 
pcrs.ppuqueries@hse.ie. Reclaims should not be sent in using this method of communication.  
Payments to community pharmacy contractors can be found within S.I. No. 279/2013 - Health 
Professionals (Reduction of Payments to Community Pharmacy Contractors) Regulations 
2013 at http://www.irishstatutebook.ie/eli/2013/si/279/made/en/pdf.  
 
6.7    Reclaims and Queries 
 
For electronic pharmacies, if a claim fails to meet the criteria for payment an exception file 
providing the reason for rejection is sent approx 24 hours after the electronic payment file is 
transmitted to PCERS.  Reclaims should be updated and resubmitted on the final exception 
file no later than midnight on the 8th working day.  
In order to submit reclaims after this timeframe (and if your software allows) you must ensure 
your final exception file is downloaded. For further information regarding reclaim submission 
and to check if your software provides this facility, contact should be made directly with your 
software vendor. 
Reclaims where additional information is required to generate reimbursement should be 
submitted to:  
Pharmacy Processing Unit  
P.O Box 7062 
Finglas  
Dublin 11 
Eircode: D11 PXT0 
 
Queries can be submitted using the Pharmacy Query Form which is available for download 
on the Pharmacy Application Suite and also at www.pcrs.ie > Online Services > Services for 
Pharmacists Only > Query Form for Pharmacists .   Reclaims should not be sent in using 
this method of communication. 
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6.8    Withholding Tax from Payments for Professional Services 
 
Under the terms of the Finance Act, the Primary Care Eligibility & Reimbursement Service is 
obliged to deduct Withholding Tax (currently 20%) from all payments for professional services 
by pharmacists under all Schemes administered by the Primary Care Eligibility & 
Reimbursement Service. 
Each pharmacy is required under the relevant legislation to furnish the Primary Care Eligibility 
& Reimbursement Service with his/her income tax reference number on their contract.  The 
Primary Care Eligibility & Reimbursement Service will issue completed Form F45-1 showing 
details of the taxable element of their payment and tax deducted to each pharmacist who has 
submitted a Tax Reference Number – such information is also shown on monthly Detailed 
Payment Listings. 
Where a pharmacist fails to furnish a tax reference number the Primary Care Eligibility & 
Reimbursement Service will be obliged to deduct the tax but no Form F45-1 will issue until the 
tax reference number provided.  Upon receipt and provision of the relevant tax number a Form 
F45-1 will issue. It appears that in such circumstances a pharmacist would be unable to make 
a claim to the Inspector of Taxes in respect of Withholding Tax paid. 
In the event F45-1 is misplaced a fee of €12.70, per month, is applicable in order to arrange a 
reprint. In these cases and F43 will issue. 
Any queries a pharmacist may have in relation to Withholding Tax should be directed to the 
Inspector of Taxes for the pharmacist’s own region. 
 
6.9    E-Tax Clearance 
 
Tax Clearance Status for all suppliers and service providers who receive payments in excess 
of €10,000 within a twelve-month period must be confirmed prior to release of each payment. 
Contractors must satisfy themselves, they have a valid Tax Clearance Certificate (TCC). Full 
details on how to apply for e-Tax Clearance are available directly from the Irish Revenue 
website on www.revenue.ie.   
 
FAQs in relation to e-Tax Clearance can be found at: http://www.revenue.ie/en/online/etax-
clearancefaqs.html#section18, The Tax Clearance Status of all relevant recipients will be 
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checked on a monthly basis through online data upload. It is important to note that until Tax 
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7. Pharmacy Services 
 
7.1    Seasonal Flu Vaccination Campaign 
 
In 2011 the administration of vaccines by community pharmacists was introduced to deliver 
the Flu Vaccination for a specified target population.  
 
The target population for influenza vaccination by Community Pharmacy Contractors with 
the required training is those aged 10 years and older in the at-risk groups defined as the 
following: 
 
A Chronic Respiratory Disease (including COPD, Cystic Fibrosis, moderate to severe 
asthma or bronchopulmonary dysplasia) 
B Pregnant Women (vaccine can be given at any stage of pregnancy) 
C Chronic Heart Disease (this includes anyone who has a history of having a “heart attack” 
or unstable angina) 
D Chronic Renal Failure 
E Chronic Liver Disease 
F Chronic Neurological Disease (including MS, hereditary and degenerative disorders of the 
central nervous system) 
G Immunosuppressed due to disease or treatment (these include anyone on treatment for 
cancer) 
H Household contacts or out of home carer (to persons with increased medical risk) 
I Diabetes Mellitus 
J Morbidly Obese (i.e. body mass index over 40) 
K Haemoglobinopathies 
M Residents of a nursing home or other long stay facility (only when vaccinated within the 
Pharmacy setting) 
O Carers (the main carers of those in the at risk groups) 
P People in close contact with pigs, poultry or water fowl 
R Health Care worker - Medical/Dental 
S Health Care worker - Nursing 
T Health Care worker - Health and Social Staff 
U Health Care worker - Management/Administration 
V Health Care worker - General Support Staff 
W Other Health Care worker 
X Age 65 and over 
AL Down Syndrome 
 
The online browser has been enhanced to allow pharmacies to record details of Pneumococcal 
Polysaccharide vaccination and Herpes Zoster vaccines administered to private patients.  
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Reimbursement for vaccination claims is made via the ‘Vaccination Services’ link under the 
claiming option on the ‘Pharmacy Application Suite’. Details of claims which have paid will be 
identified on your GMS Detailed Payment Listings.  
 
Claims which fail to meet the criteria for payment may only be updated via the online browser. 
In order to edit a claim please follow the following procedure.  
 Click on Previous Claim tab on top of screen 
 Use the drop down ‘Filter by date’ to retrieve claims for a specific period.  
 If you know the claim number you may enter this in Search field (top right of screen) 
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 Click on the ‘pencil’ icon on the right hand side of screen to edit to alter the claim or 
the ‘Trash’ icon to delete the claim.  
 
 
Details of the approved batch numbers of Influenza, Pneumococcal and Herpes Zoster 
vaccines will be available on the drop down selection list of the online Pharmacy Vaccination 
Claiming system. The regulations require that all vaccinations, whether with HSE-supplied 
vaccine stock or other stock, must be notified to the HSE. This can be completed through the 
online portal.  
The Secure Checker has recently been enhanced to allow Pharmacists and GPs to see the 
last record date of Influenza and Pneumococcal vaccinations. This is listed under ‘Vaccination 
Services’. 
 
Those pharmacies who registered previously and hold an account with the National Cold 
Chain Service are not required to register again. However, if your pharmacy has not registered 
for a National Cold Chain account, you must complete the form provided by National Cold 
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7.2    Emergency Hormonal Contraception (EHC) Service 
 
From 1st July 2017, female medical card holders are able to obtain Emergency Hormonal 
Contraception (EHC) directly from their pharmacist, without a GP prescription, following a 
pharmacist delivered consultation. No prescription charge is incurred by the patient. 
The Health Professionals (Reduction of Payments to Community Pharmacy Contractors) 
(Amendment) Regulations 2017, Schedule 2 sets out the payment of €11.50 plus dispensing 
fee as applicable per provision of EHC service without a prescription from a GP under the 
GMS scheme. 
 
7.2.1 Claiming for the EHC Service 
 
The Pharmacist is paid a consultation fee where they have exercised their professional 
judgement in respect of EHC. There are two professional service reimbursable codes: 
 
It is recognised that in a very limited number of circumstances following Pharmacist 
consultation, supply of emergency contraception is not appropriate and therefore the service 
fee can be claimed using the code assigned to non-supply of product. 
The service is recorded through the normal GMS claims procedure with the relevant 
reimbursement code(s) provided. 
1) The Pharmacy Contract Number must be inserted in the ‘Prescriber’ field. The 
pharmacist enters code for consultation (a) with supply or (b) without supply. If a 
consult results in supply, pharmacist states the product dispensed. 
2) The patient must sign the Unified Claim Form (UCF) to confirm that they have received 
the service. 
3) The Pharmacist confirms using the following text on the UCF that they have provided 
the service in line with the relevant protocol: 
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(ii)  ‘I confirm that I have counselled the patient and provided the service 
and/or product listed in compliance with the relevant protocol’ 
(iii) Pharmacist signature and PSI Registration Number of the Pharmacist 
4) The top copy of the UCF is submitted with GMS claims bundle as supporting paper 
documentation using form number format. 
You are reminded that this service is applicable to valid medical card holders and is exempt 
from prescription charges. A prescription charge will not be deducted from your GMS payment 
in respect of this service. 
 
7.3    HIV Pre-Exposure Prophylaxis (PrEP) 
 
HIV Pre-Exposure Prophylaxis (PrEP) is the pre-emptive use of oral antiretroviral therapy 
(ART) in HIV negative people to reduce the risk of HIV infection. Since 4th November 2019, 
the HSE approved reimbursement for a fixed dose combination of oral emtricitabine/tenofovir 
under GMS and DPS for HSE approved persons only.  
 
No prescription charge is incurred by the patient when they are approved by the HSE as the 
product is exempt from prescription charges. Approved patients can also access these 
medicines under their DPS eligibility without charge. 
 
A reimbursement application system is in place to ensure appropriate patients access the 
programme in line with national guidelines from approved prescribers.  
 
Service users are being informed by relevant HSE services that PrEP will be dispensed 
through community pharmacies and that they will need GMS or DPS eligibility to access free 
PrEP from the HSE.  However, there may be clinically eligible and physician approved service 
users who have not yet received or applied for their DPS when they present with a PrEP 
prescription. While pharmacies can assist in registering patients for express DPS, the patient 
must complete the eligibility process for their ‘patient specific’ approval information to become 
visible on the Secure Checker.  Approval can be confirmed through the ‘Eligibility Confirmation’ 
on the Pharmacy Application Suite under ‘Patient Specific Arrangements’.  
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Pharmacies can claim for Emtricitabine/Tenofovir electronically using the relevant 











200mg/245mg Film Coated 
Tablets x 30 
€45.00 €48.60 
77101 Emtricitabine/Tenofovir 
disoproxil Teva 200mg/245mg 
Film Coated Tablets x 30 
€48.50 €52.38 
 
Reimbursement Claims submitted for patients who are not HSE approved will not be paid.  
 
7.4   Pharmacy Training Grant 
 
Only courses approved for the Training Grant are eligible.  
Course 
Code 
Description of Course Maximum 
Payable 
IPU 01 The former IPU Medicines Counter Assistant Course 1 (MCA 1) €550 
IPU 02 The former IPU Medicines Counter Assistant Course 2 (MCA 2) €550 
IPU 03 The current IPU Medicines Counter Assistant (MCA) Course €550 
IPU 04 Year 1 IPU Pharmacy Technicians Course €1270 
IPU 05 Year 2 IPU Pharmacy Technicians Course €1270 
IPU 06 IPU Pharmacy Interact Course €260 
IPU 07 IPU Pharmacy InterLink Course €260 
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PTG 11 Cardiovascular Risk Assessment Training  €250 
PTG 12 CPR course (Multiple Providers) €95 
PTG 13 Parenteral Administration of Medicines (Hibernian Healthcare 
Delivered)  
€365 
*This list is subject to change  
These arrangements extend to any staff member who is employed in a pharmacy on a 
continuous basis. The Training Grant covers course fees only. Ancillary costs such as locum, 
travel and accommodation expenses are not covered by the grant. 
A single application should be submitted by the 31st March each year in respect of courses 
completed by pharmacy staff in the previous year. The annual application should include the 
completed Pharmacy Training Grant Summary Form, and the individual Pharmacy Training 
Grant Claim Form(s) covering all relevant staff in the pharmacy. Each application, which 
should be forwarded to the relevant HSE Pharmacist at Community level, should also include 
the pharmacy staff training plan for the current year. 
A Pharmacy Training Grant Claim Form should only be submitted in respect of a course 
when evidence of satisfactory course completion is available to support the claim. For 
modular courses, a claim may be submitted based on the successful completion of each 
individual module, or a number of completed modules.The maximum amount payable per 
pharmacy contractor in respect of a calendar year is €1,270.  
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8. Supporting Tools  
8.1    Pharmacy Application Suite 
 
All contractors have access to the Pharmacy Application Suite. The services available on the 
suite are: 
Claiming 
 Vaccination Services 
 Phased Dispensing 
 Transmission History 
Eligibility Confirmation 
Reporting 
 GMS Listings 
 DPS Listings 
 Methadone Listings 
Correspondence 
 Drug Payment Scheme & Prescription Charge 
 Pharmacy Query Form 
 Circulars 
Supplies (stationary, unified claims forms etc.) 
High Tech Module 
 High Tech Stock Return System 
 High Tech Stock Take 
 High Tech Hub 
Express DPS 
Information 
 Termination of Pregnancy 
Express LTI  
LTI Drug Request 
 
Access to the suite requires a digital certificate and must be installed on the user’s PC. 
Certificate codes are issued by I.T Operations at PCERS. The URL to access the Pharmacy 
Application Suite is https://secure.sspcrs.ie/portal/pharmsuite/sec  
If you are interested in registering or if your certificate codes are nearing expiration please 
complete and forward the application form which is available on 
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www.pcrs.ie>onlineservices>servicesavailabletopharmacists to our IT Support dedicated 
email at cert.info@hse.ie   
 
Alternatively you can fax your application form to 01-8343589. Please note a separate 
registration is required per PC and or GMS Panel Number.  
For further queries please contact the pharmacy Processing Unit directly via phone or email 
on 01-8647100 or pcrs.ppuqueries@hse.ie.  
 
8.2   Secure Scheme Checker 
 
Online Eligibility Confirmation is available under the ‘Online Services’ link at www.pcrs.ie. A 
further tool which assists eligibility verification is the ‘Secure Checker’. This facility is accessed 
via the ‘Pharmacy Application Suite’.  
The PCERS has gradually enhanced the secure checker facility in order to assist you at patient 
level. Some of the enhancements include: 
 A search function to retrieve all patient specific eligibility using the client’s PPSN 
 A Family Grouping option, which displays details of persons in family grouping in order 
to retrieve family member specific eligibility 
 A Patient Specific Arrangements option which can be used to check if a patient is 
approved for; 
- Phased dispensing  
- Special drugs requests (e.g. additional diabetic test strips, Fampridine, 
Lidocaine 5% medicated plasters, FreeStyle Libre, DOACs, Entresto, ONS)  
 The patient’s Prescription Charge Status. 
 LTI Information: LTI illness code(s) and a link to the Core List(s) directly from Secure 
Checker. A further development is also in place which provides the confirmation of 
items which have specific individual approval outside of the Core List(s) for a particular 
patient.  
 Application for additional items to be added to the LTI card for an individual.   
 Pharmacists and GPs to see the last record date of Influenza and Pneumococcal 
vaccinations. This is listed under ‘Vaccination Services’. 
As further developments are planned Pharmacists will be kept informed accordingly.Your 
vendor may have already integrated their system in-line with HSE services. Contact should 
be made with your vendor for further information.  
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8.3   Pharmacy Circulars 
Pharmacy Circulars are availabe on the PCERS website at www.pcrs.ie > Circulars for 
Contractors > Pharmacy Circulars. Going forward all circulars issued to pharmacy will only be 
published online via Pharmacy Suite and HSE website.  
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8.4   Frequently Asked Questions 
How can I confirm a 
patients medical card 
eligibility at point of 
service?  
To assist contractors a specific tool to verify a client’s eligibility 
prior to providing services has been deployed. This facility is 
available at  
 
 www.pcrs.ie > Online Services > Online Eligibility 
Confirmation  
 
An SMS facility is also available. To use the tool enter the word 
‘check’ followed by a space then the client identifier, i.e. card 
number and client code letter (for GMS, DPS and HAA) with no 
spaces to 087 9097867.  
 For Example check 1234567A 
 
Confirmation may also be obtained via the ‘Pharmacy Application 
Suite’ which can be accessed through  
 www.pcrs.ie > Online Services > Services For 
Pharmacists only 
 
Please note GP Visit Card holders are not entitled to receive 
prescribed medicines and appliances under GMS Scheme.  
 




The PCERS Pharmacy Application suite may be accessed at: 
www.pcrs.ie > Online Services > Pharmacy Application Suite 
 
Please note a security cert must be downloaded prior to access. 
A User Access Registration Form may be ordered by emailing 
cert.info@hse.ie  
 
My security certificate 
has expired, who is the 
contact in PCERS? 
Contact cert.info@hse.ie quoting your GMS panel number and a 
member of our Information and Communications Department will 
contact you.  
 
What information/tools 
are available to me on 
the ‘PCERS Application 
Suite’? 
The ‘Pharmacy Application Suite’ allows the pharmacists access 
to: 
Claiming 
 Vaccination Services 
 Phased Dispensing 





 GMS Listings 
 DPS Listings 
 Methadone Listings 
Correspondence 
 Drug Payment Scheme & Prescription Charge 
 Pharmacy Query Form 
 Circulars 
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Supplies (stationary, unified claims forms etc.) 
 
High Tech Module 
 High Tech Stock Return System 
 High Tech Stock Take 









LTI Drug Request 
Which drugs/services 
may be applied for 
online via the Pharmacy 
Application Suite? 
 Phased Dispensing  
 High Tech Ordering and Management 
 Express DPS Registrations 
 Ordering of Supplies 
 Vaccination Services 
 Express LTI 
 Special Drug Requests - LTI 
 
Queries in relation to Special Drug/Phased approval requests are 
managed by the Pharmacy Function Unit on 01 864 7100. 
 
Are EU Claims 
applicable as hospital 
emergency claims?    
A hospital emergency claim from a qualifying hospital may be 
made for EU patients. The pharmacist can submit an EU Hospital 
emergency claim subject to a maximum of a 7 day supply. The 
claim should be submitted on a unified claim form and in all cases 
a copy of the Irish hospital prescription should accompany the 
claim.  
 
See Circular 35/17 for full details of qualifying hospitals.   
 
How do I find the drug 
code for a specific item? 
An up to date list of reimbursable drugs is available for review at:   
www.pcrs.ie > List of Reimbursable Items 
 
You may search for details of items which are payable under GMS 
and DPS. Please be aware only licensed drugs show on the list. 
 




Drug code is no longer valid and will not be reimbursed by 
PCERS. 
Can I submit duplicate 
claims/codes for 
reimbursement? 
Under no circumstances should a duplicate claim be submitted to 
PCERS for reimbursement. Only one of the same drug code 
should be listed as a line item on a claim form. Items should not 
be split into seperate items to facilitate multiple flavours. 
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Explain the error code 
message “not 
participating in scheme 
on date of claim”. 
This confirms the claiming contractor was not participating in the 
scheme on date of dispensing.  
 
If contract number has recently changed please ensure claim was 
submitted under correct GMS Panel number. 
 
Explain the error code 
message “No paperwork 
received please provide 
original claim” 
 
Supporting documentation for a specific claim has not been 
received at PCERS.  
Explain the error code 
message “no claim 
made on form” on 
Dental/EU claims. 
 
This error message issues to advise that the prescription had no 
drug codes on the claim form. 
 
Explain the error code 
“Unable to claim service 
code with presciption”.  
This error relates to Emergency Hormonal Contraception and 
occurs where the patient’s GP number has been submitted on 
claim. The Pharmacy Contract Number must always be inserted 
in the ‘Prescriber’ field.  
 
How do I proceed with a 
blue Termination of 
Pregnancy stock order 
form? 
Pharmacy authorisation by the HSE to access stock from the 
supplier must be received prior to proceeding and can take a 
maximum of 48 hours. This is a once-off process and the 
pharmacy will be authorised to obtain stocks of product thereafter.  
 
Please continue to notify the HSE by forwarding the blue stock 
order forms to pharmacy.response@hse.ie. 
 






reimbursed on GMS 





Are Bandages and 
Dressings (Wound 
Management Products) 
allowed on GMS scripts? 
 
No 
Is Nicotine Replacement 
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Is Compression Hosiery 
covered on DPS? 
 
No 
How do I submit an 
express DPS claim? 
Since November 2018, a new process was introduced for online 
DPS express applications by the Community Pharmacist. This 
online application is available on the Pharmacy Suite under 
“Emergency DPS”. 
 
When submitting a claim for reimbursement please ensure to 
include an X as the patient code letter after the express DPS Card 
No. (EDPS). For example the below card number should be 




This process will facilitate DPS eligibility on a temporary basis 
only. Failure on behalf of the patient to register for the DPS 
scheme will result in losing DPS eligibility after 3 months. 
 
An ‘Emergency DPS Pharmacy User Guide’ is also available on 
the Pharmacy Application Suite for Review.  
 
Patients may apply online for the Drugs Payment Scheme either 
online at www.myDPS.ie or, by completing an application form 
and posting to:- 
Drugs Payment Scheme 
Client Registration Unit 




What is maximum 
reimbursable quantity 
per month for Zyban? 
 
A maximum quantity of 60 Zyban is reimbursed by PCERS.  
 
 
What is the maximum 




The maximum reimbursable level on the GMS & Community 
Drugs Schemes is four tablets per month. 
 
See Circular 9/17 for details of reimbursable products.  
What is the maximum 
reimburseable quantity 
of Blood Glucose Test 
Strips for patients with 
type 2 Diabetes? 
There is no limit for patients treated with insulin. 
 
Patients managed on sulphonylurea or meglitinide drugs will be 
reimbursed for 2 boxes of test strips per month i.e. 1,200 test 
strips/annum. 
 
Patients managed on oral hypoglycaemic drugs other than 
sulphonylurea or meglitinide drugs will be reimbursed for 1 box of 
test strips per month i.e. 600 test strips/annum. 
 
Patients managed through diet alone will be reimbursed for 2 
boxes of test strips within a 12 month period. 
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For further queries refer to Circ11/16 or contact the Pharmacy 
Function Unit on 01 864 7100. 
 
What is the maximum 
reimbursed quantity of 
Victoza® (Liraglutide) 
per month? 
The maximum quantity allowed under GMS and LTI is one box of 
Victoza® per month (or a maximum of three pens). Prescriptions 
for Liraglutide (Victoza®) at doses in excess of 1.8 mg are outside 
the licensed indication and may not be reimbursed. 




The recommended dose of Prolia is 60 mg administered as a 
single injection every 6 months. Where a claim is submitted in a 
shorter timeframe than expected for a patient using this 
medication, Pharmacists will see an error message on their 
detailed payment listings. Where this occurs, an automatic mark-
down will be applied. 
 
How do I know if a 
patient qualifies for 
phased dispensing? 
All patients must now be approved for phased dispensing. 
Approval can be sought by the GP or Pharmacist. Once the 
patient is approved, they can attend any pharmacy for a phased 
dispensing service .  
 
The Phased Applications System is found in the Pharmacy 
Application suite under: 
Claiming> Phased Dispensing. 
 
Eligibility in relation to patient approval for phased dispensing may 
be viewed on the Secure Scheme Checker under ‘Patient Specific 
Arrangements’. 
 
Is phased dispensing 
permitted for Nursing 
Home patients? 
 
Phased dispensing for Nursing Home patients is not permitted. 
See Circular 019/07.  
Who do I contact with 
queries in relation to 
Special Drug Requests 
or Phased dispensing? 
Contact should be made with the Pharmacy Function Unit on 01 




What are the 
requirements for a ‘Do 
Not Substitute’ 
prescription? 
From 1 August 2014, the HSE will reimburse the notified 
reference price for relevant interchangeable products unless ‘Do 
Not Substitute’ is handwritten on the prescription by patients GP. 
 
Pharmacists are asked to record how the medical practitioner has 
prescribed by confirming one of the following:  
a) INN prescribed  
b) Branded Generic Prescribed  
c) Proprietary Prescribed  
d) Do Not Substitute invoked.  
 
If a patient presents a Non GMS prescription where the prescriber 
has written ‘Do Not Substitute’ please ensure that a photocopy of 
the prescription is retained on your premises for audit purposes.  
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Who do I contact with 
queries in respect of 
Hepatitis B vaccinations 
for pharmacy staff? 
 
Only pharmacies registered for Methadone/Suboxone dispensing 
or needle exchange may avail of this service. Queries are 
managed via the Contract Support Team at 01 8647100. 
 
How do I claim for an 
exempt medicinal 
product? 
Claims for Unlicienced Medicines on the Exempt Medicinal 
Products List can be submitted to PCERS using the codes 
specified, in the usual manner. (Ref Circular 039/16).  
 
Unlicensed Medicinal products not included on the Exempt list 
where prescribed for persons with GMS eligibility will require 
individual approval at Community Health Organisation level. 
Payment will subsequently issue locally under the Discretionary 
Hardship Arrangements. 
  
Unlicensed Medicinal Products not included on the Exempt List 
that are approved under the DPS/LTI & HAA scheme are 
submitted through the established arrangements using 77750 
codes (no VAT) & 77751 / 77752 (VAT). A copy of the relevant 
invoice is required and must accompany such claims. In all cases 
where an invoice is not attached, the claim will be rejected for 
payment.  
 
Please note not all unlicensed medication are covered.  
 
Hand priced codes such as 44444, 55555 & 66666 are no 
longer to be used when submitting claims. Claims submitted 
in this fashion will also be rejected for payment.  
 
In relation to 
extemporaneous claims, 
what does error 




A full breakdown of all components used must be submitted to 




How do I claim 
reimbursement for BMX 
mouthwash? 
BMX mouthwash is claimed using the extemporaneous code 
99XXX for oral medication depending on the scheme.  A full 
breakdown of all components used must be submitted for 
payment.  See Circular 11/09 for full list of codes and further 
details.  
 
Is it necessary for 




It is a requirement under all schemes that third party verification 
is received. It is also required in order to properly present a valid 
claim for reimbursement. 
 
Who can collect 
medication on behalf of 
a patient? 
The pharmacist should be satisfied the person collecting 
medication on behalf of a patient is acting on behalf of the patient.  
The relationship of the person collecting the medication could 
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The pharmacist must be satisfied that the person collecting the 
medicine has been authorised to do so by the patient and is of a 
sufficient age and maturity to safely deliver the medicine to the 
patient with any relevant information. 
 
Under DPS Scheme what 
is the 13th dispensing 
process? 
The 13th dispensing process under the Drugs Payments Scheme 
ensures no individual or family group with a valid DPS card will 
pay more than €124*(current threshold amount) in a calendar 
month, i.e. €124* x 12 in a full year, for approved medicines & 
appliances.  
 
The payment of a second €124* in any month for the same 
pharmacy should only arise where a person is intentionally 
receiving the next month’s supply on the grounds that he/she will 
be away the following month or for other such reason. In this 
situation, a second co-payment for the next month’s medicines 
should be paid to the Pharmacist for these items. 
 
The only exception to this is where the packaging of a particular 
medicine or appliance is such that a client requires 13 dispensing 
in a 12 month period, example 28 day packs. In this situation, to 
ensure that no individual or family makes more than 12 payments 
in a year, it is suggested that, where appropriate, once in a 12 
month period, or periodically throughout the year, more than a 28 
day supply is given. The packaging will influence how this can be 
achieved. 
 
Quantities dispensed should correspond with a valid prescription 
recognising that clause 4(2) of the Community Pharmacy 
Contractor Agreement allows for professional judgement and 
discretion.  
 
Explain the procedure to 
follow when a supplier is 
unable to provide an 
Unlicensed Medicinal 
Product at the price 
specified on the HSE 
list.  
 
Contact should be made with the HSE by emailing 
PCRS.ExemptMed@hse.ie. See Cirular 039/16 for full details. 
Where is the list of 
reimbursable items on 
Pink Stock orders 
found? 
The list of GMS reimbursable products is available for download 
or review at:   
www.pcrs.ie > List of Reimbursable Items > Dressings (Pink 
Stock Order Forms).   
 
Where can l access the 




The list of GMS reimbursable products is available at:  
www.pcrs.ie > List of Reimbursable Items > Dental Prescribable 
Items.    
  
What medicines are 
reimbursable under the 
Only medicines on the core list which are approved for specific 
medical conditions are reimbursed seamlessly by PCERS.  
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Long Term Illness 
Scheme? 




When patients approved medicines are changed or additional 
items are prescribed for their Long Term Illness(es), approval 
must be sought from the PCERS.  
 
How do I submit my 
Reclaims/Queries 
For electronic pharmacists if a claim fails to meet the criteria for 
payment an exception file providing the reason for rejection is 
sent approx 24 hours after the electronic payment file is 
transmitted to PCERS.  
 
Reclaims should be updated and resubmitted on the final 
exception file no later than midnight on the 8th working day.  
 
In order to submit reclaims after this timeframe (and if your 
software allows) you must ensure your final exception file is 
downloaded. For further information re reclaim submission and to 
check if your software provides this facility, contact should be 
made directly with your software vendor. 
  
Reclaims where additional information is required to generate 
reimbursement should be submitted to:  
Pharmacy Processing Unit  




Queries can be submitted using the Pharmacy Query Form which 
is available for download on the Pharmacy Application Suite and 
also at 
 
www.pcrs.ie > Online Services > Services for Pharmacists Only > 
Query Form for Pharmacists 
 
How do I order Yellow 
Bags? 
Yellow bags may be ordered by emailing PCRS.Supplies@hse.ie 
or, alternatively, you may fax an order to 01 8343535. 
 
What are medical card 
prescription charges.  
With effect from the 1st of April 2019 Prescription charge rates for 
patients over 70 reduced to €1.50 per line item with the monthly 
cap reduced to €15. This reduction will also apply to thier 
dependants.  
 
The Secure Checker curently available on the Pharmacy 
Application Suite will identify the amount payable per 
patient/family.  
 
Further information in relation to family groupings and FAQ’s are 
available on www.medicalcard.ie . 
 
What is the threshold for 
DPS payments per 
month? 
Under the Drugs Payment Scheme, an individual or family in 
Ireland currently will pay €124 each month for approved 
prescribed drugs, medicines or rental costs for CPAP/oxygen, for 
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use by that person or his or her family. A family is an adult, their 
spouse or partner and any dependents. 
You can include any family member, regardless of age, who can’t 
fully maintain themselves and has: 
 A physical disability 
 An intellectual disability 
 An illness 
 
An medical report is required for the applicants who cannot 
maintain themselves. 
 
Dependents over 18 years and under 23 years of age who are in 
full time education may also be included.  
 
Bi-annually where a patient has paid in excess of the monthly 
threshold as they attended multiple pharmacies, the PCERS 
refund the patient/family automatically without the need to apply.  
 
How do I access the 
most up to date circulars 
issued by PCERS? 
All circulars issued are available for review and download on 
www.pcrs.ie > Circulars for Contractors >  Pharmacy Circulars   
 
A link to the above is also available via the Circulars tab on the 
Pharmacy Application suite.  
 
 
What if a patient 
presents with a 
prescrition who has no 
medical card eligibility? 
Only patients who have a valid GMS card may receive certain 
treatments free (except for the statutory prescription charge) 
under the GMS Scheme. Eligibility can be confirmed 24 hours a 
day using the PCERS Secure Checker.  
 
Those who do not fall into this category should be treated under 
the Drugs Payment Scheme.  
 
A letter should be provided to patients with invalid/expired 
eligibility which will redirect them to contact the PCERS National 
Medical Card Unit. A template letter can be downloaded and 
provided to them for their information. This form is available at  
 
www.pcrs.ie > Online Services > Services for Pharmacists Only > 




I have submitted a claim 
for a patient whose card 
is expired. Will the claim 
pay? 
Under the current term of the Incomplete Protocol, only claims 
where the claiming patient had full GMS eligibility within 2 months 
of the date of claim and the claiming pharmacy Incomplete Claims 
Percentage is decreasing progressively or the percentage is 0.1% 
or less will process for payment. 
 
Your Incomplete Claims Progress Report is available to view on 
your Detailed Payment Listings.  
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9. Appendix 
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